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1214Objective: We examined the effects of cardiothoracic surgery, including cardiopulmonary bypass and con-
trolled mechanical ventilation, on messenger RNA gene expression in human diaphragm. We hypothesized
that genes responsible for stress response, redox regulation, protein turnover, energymetabolism, and contractile
function would be altered by cardiothoracic surgery.
Methods: Paired diaphragm biopsy samples were obtained from 5 male patients (67 11 years) during cardio-
thoracic surgery, the first as soon as the diaphragm was exposed and the second as late in surgery as possible (4.9
 1.8 hours between samples). We profiled messenger RNA from 5 specimen pairs with microarray analysis (Hu
U133 plus 2.0; Affymetrix UK Ltd, High Wycombe, UK). Quantitative reverse transcriptase polymerase chain
reaction was performed with a select set of genes exhibiting differential expression for validation.
Results:Microarray analysis identified 779 differentially expressed (early vs late samples) unique gene products
(P<.005). Postoperatively, genes related to stress response and redox regulation were upregulated. Additionally,
we found significantly upregulated expression of cathepsin C (2.7-fold), cathepsin L1 (2.0-fold), various
ubiquitin-conjugating enzymes (E2, approximately 1.8-fold), proinflammatory cytokine interleukin 6 (15.6-
fold), and muscle-specific ubiquitin ligase (MuRF-1, 2.6-fold). Comparison of fold change values obtained
by quantitative reverse transcriptase polymerase chain reaction and microarray yielded significant correlation
(r ¼ 0.95, P<.0001).
Conclusions: Cardiothoracic surgery results in rapid changes in human diaphragm gene expression in the op-
erating room, including genes related to stress response, inflammation, redox regulation, and proteolysis. These
results may provide insight into diaphragmmuscle biology after prolonged cardiothoracic procedures. (J Thorac
Cardiovasc Surg 2011;142:1214-22)Supplemental material is available online.
After cardiothoracic surgery (CTS), approximately 10% of
patients require prolonged mechanical ventilation (MV,
support needed for at least 48 hours after surgery), and
more than 40% in-hospital mortality has been reported in
this population.1 Although the mechanisms responsible
for the need for prolonged MV have not been fully eluci-
dated, accumulating evidence links prolonged MV with in-
spiratory muscle dysfunction.2 Animal studies have showne Departments of Physical Therapy,a Surgery,b Molecular Genetics and Mi-
logy,c and Physiological Sciences,d University of Florida, Gainesville, Fla.
ed by National Institutes of Health grant T32 HD043730 and a Foundation for
cal Therapy Promotion of Doctoral Studies Scholarship (to B.K.S.).
res: Authors have nothing to disclose with regard to commercial support.
d for publication Dec 8, 2010; revisions received Feb 7, 2011; accepted for
ation Feb 22, 2011; available ahead of print April 4, 2011.
for reprints: A. Daniel Martin, PhD, PT, PO Box 100154, Gainesville, FL
-0154 (E-mail: dmartin@phhp.ufl.edu).
23/$36.00
ht  2011 by The American Association for Thoracic Surgery
016/j.jtcvs.2011.02.025
The Journal of Thoracic and Cardiovascular Surthat MVuse itself leads to a rapid, time-dependent decrease
in diaphragmatic contractility.3 DeRuisseau and col-
leagues4 examined diaphragm gene expression after 6 to
18 hours of controlled MV in rats and found significant up-
regulation of genes related to cell growth and maintenance,
stress response, and nucleic acid metabolism, with concom-
itant downregulation in the structural protein and energy
metabolism categories. In contrast, preservation of dia-
phragm activity with assisted MV modes5 or short periods
of spontaneous respiration6 lessens contractile dysfunction
in animals supported with MV. In human studies, Levine
and associates7 showed clinically significant diaphragm
muscle atrophy after as little as 18 to 69 hours of controlled
MV, which is consistent with the changes seen in the animal
models.
In addition to MV itself, other factors during CTS may
also influence diaphragm function, such as the use of cardio-
pulmonary bypass (CPB),8 hypothermia,9 and neuromuscu-
lar blockade.10 Data suggest that these factors can affect
diaphragm contractile properties or neuromuscular transmis-
sion alone or in combination with the use of controlled MV.
Ermilov and coworkers8 found that a 1-hour exposure to CPB
followed by a 90-minute recovery period resulted in an ap-
proximately 25% decline in diaphragm-specific forcegery c November 2011
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
CTS ¼ cardiothoracic surgery
IL ¼ interleukin
JAK-
STAT
¼ janus kinase/signal transducers and
activators of transcription
MV ¼ mechanical ventilation
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to time-matched rats supported with MV without CBP. Dur-
ing CPB, the expressions of proinflammatory cytokines such
as interleukin (IL) 6 and IL-8 surge in respiratory muscle,11
and elevated levels of these cytokines have been associated
with diaphragm contractile dysfunction.8 These findings sug-
gest that the stressor of CTS may alter diaphragm function
very rapidly and that cytokine expression could contribute
to diaphragm dysfunction. It is unknown, however, whether
or how rapidly messenger RNA gene expression in the hu-
man diaphragm is altered by CTS.
The objective of this study was therefore to examine the
effects of CTS, which include the use of controlled MV in
combination with the use of CPB, hypothermia, or both,
on messenger RNA gene expression in the human dia-
phragm. We hypothesized that the expression of stress re-
sponse, redox regulation, and proteolysis genes would be
predominantly increased during the course of CTS, whereas
energy metabolism, cell cycle, and contractile function
would be predominantly decreased.
MATERIALS AND METHODS
Subjects
As a sample of convenience, 6 male patients 50 years old or older un-
dergoing aortic repair were recruited for this prospective, observational,
and repeated-measures design study. One subject (patient 2) was ex-
cluded as a result of technical failure with the analysis; thus there were
only 5 subjects’ specimens used in the final analysis. The institutional
review broad at University of Florida approved the protocol, and partic-
ipants gave their written consent. The exclusion criteria consisted of New
York Heart Association functional class III or IV cardiac disease; history
of stroke, cerebrovascular disease, spinal cord injury, or progressive neu-
romuscular disease; CTS within the previous 12 weeks; a history of pneu-
monectomy or lung surgery; skeletal pathology, such as scoliosis; forced
expiratory volume in 1 second less than 60% of the age-predicted value;
and malignancy.
Surgical Procedure
All patients underwent a median sternotomy and CPB. Patients under-
going arch aortic surgery were selected because of the longer surgical
time course, and all operations were performed by the same surgeon
(T.M.B.). Hypothermic CPB (temperatures of 18C–24C) with antegrade
and retrograde blood cardioplegia was used in all cases, with brief periods
of hypothermic circulatory arrest during the proximal arch anastomosis. A
1-g bolus of methylprednisolone sodium succinate (Solu-medrol; Pharma-
cia and Upjohn, Kalamazoo, Mich) was in the prime solution on initiation
of CPB. During CPB, mean arterial pressure of 50 to 80 mm Hg and bloodThe Journal of Thoracic and Carflows of 2.4 to 2.8 L/(min $ m2) were maintained. The hematocrit was
maintained above 20% during CPB. The use of vasoactive drugs was at
the discretion of the anesthesiologist managing the case. Patients were
actively rewarmed to 36.5C before weaning from CPB. After surgery,
all patients were transferred to the cardiothoracic intensive care unit for
recovery.
Anesthetic Management
A preoperative dose of vancomycin (1–4 mg) was given intravenously.
A standard anesthesia regimen was used in all patients. Subjects were
intubated and administered general anesthesia by the anesthesiologist.
Controlled MV was maintained at 5 cycles/min with a tidal volume of 5
to 7 mL/kg. Anesthetic induction consisted of fentanyl, propofol, midazo-
lam (Versed; F. Hoffmann-La Roche AG, Basel, Switzerland), vancomy-
cin, and vecuronium bromide. Intraoperative paralysis was sustained
with vecuronium bromide (0.6–0.8 mg/kg) or pancuronium bromide
(0.1–0.12 mg/kg).
Diaphragm Biopsies
Two full-thickness biopsy specimens (approximately 6 mm in diam-
eter) were taken from mirror-image locations of the anterolateral aspect
of the right and left hemidiaphragms near the costal margins. The first
biopsy specimen was obtained immediately after exposure of the dia-
phragm; the second biopsy specimen was obtained as late during sur-
gery as possible. Tissue samples were blotted to remove visible
blood. Each specimen was stabilized by using RNAlater solution (Am-
bion Inc, Applied Biosystems by Life Technologies Corporation, Carls-
bad, Calif) and then transferred to liquid nitrogen and stored at80C
until analysis.
RNA Isolation
The online data supplement gives details of the RNA isolation.
Complementary RNA Synthesis and Microarray
Hybridization
Complementary RNAwas synthesized according to the 2-step ampli-
fication protocol outlined by the manufacturer (Affymetrix UK Ltd, High
Wycombe, UK), with 0.4 mg of total RNA as starting material. Second,
complementary RNA was transcribed in vitro with the incorporation of
biotinylated nucleotides with an ENZO Bio Array High Yield RNA
Transcript Labeling Kit (T7; Enzo Life Sciences Inc, Farmingdale,
NY), and the biotin-labeled product was hybridized onto an Affymetrix
Hu U133 plus 2.0 GeneChip, which contains 54,675 probe sets represent-
ing more than 38,500 well-substantiated human genes. Staining and
washing followed the protocol (EukGEWSv4; Affymetrix) with a fluidics
station (Affymetrix).
Statistical Analysis of Affymetrix Microarray Gene
Expression
Data acquisition (scanning). The arrays were scanned with
a scanner (Affymetrix), and the fluorescence intensity was calculated
with Affymetrix Gene Chip Operating Software. Chip-to-chip normaliza-
tion was accomplished with dChip (Wong laboratory, Department of
Biostatistics, Harvard School of Public Health, Cambridge, Mass) normal-
ization protocols. An expression matrix was modeled with the perfect
match–only model algorithms of dChip. The details of this model are de-
scribed elsewhere.12
Gene Chip Operating Software was used to identify probe sets in which
the hybridization signal intensity was at or below background levels. Sig-
nals in these probe sets were considered to be absent. Probe sets in which
the signal intensity was absent on all arrays under study were excluded in
the following 2-step high-level statistical analysis.diovascular Surgery c Volume 142, Number 5 1215
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SUnsupervised analysis of gene expression patterns. Unsu-
pervised analysis was performed with probe sets in which the hybridization
signal intensities varied the most across the data set. Probe sets with a co-
efficient of variation greater than 0.5 were identified and subjected to hier-
archic cluster analysis with dChip clustering algorithms.12
Supervised analysis of gene expression patterns. The
dChip expression matrix was filtered to remove probe sets that were
never detected above background on any array in the analysis. Of the
10 arrays investigated, the expression of 2558 probe sets was not above
background on any array from the 54,675 probe sets present in the
Affymetrix Hu U133 plus 2.0 GeneChip. Of the remaining 52,117 probe
sets detected above background on at least 1 array, 3318 probe sets
exceeded the coefficient of variation filter of greater than 0.5 and were
subsequently subjected to hierarchic cluster analysis (Figure 1, and see
E-Materials and Methods for details). This expression matrix was
imported to BRB Array Tools (v3.4 Beta 2; http//linus.nci.nih.gov/
BRB-ArrayTools.html) for supervised analysis. BRB Array Tools was
used to identified genes that were differentially expressed between
early-surgery and late-surgery samples (paired by patients) at the P<
.005 level of significance (according to a modified Student t test). This
supervised analysis identified 1080 probe sets differentially expressed
(early vs late samples) at P<.005.
Once probe sets had been identified that were differentially expressed
between early-surgery and late-surgery samples, NetAffx query (http://FIGURE 1. This figure shows the hierarchic cluster pattern of the hybrid-
ization signal intensities of 3318 probe sets that display a coefficient of var-
iation greater than 0.5. In the heat map, the intensity of the color indicates
relative expression for each individual gene. The dendrogram of the clus-
tering (top) is used to identify similarities in expression patterns among
the arrays.
1216 The Journal of Thoracic and Cardiovascular Surwww.affymetrix.com/analysis/index.affx) was undertaken for retrieving
Gene Ontology annotations of the significant probe sets. In addition,
tabular gene expression data were published online in the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/), submission GSE19533.
Functional classification. Genes identified as significantly
different by microarray were grouped according to 2 public databases:
Gene Ontology (http://www.ncbi.nih.gov/entrez/query.fcgi?db¼OMIM)
and NetAffx (http://www.affymetix.com/analysis/netaffx/goanalysis_
netaffx4.affx).
Pathway analysis. For the 779 unique known identified genes, the
Pathway-Express, part of a package of microarray tools (http://vortex.cs.
wayne.edu/projects.htm) was used to provide searchable pathways that
related to the significant gene products in our study. The Pathway-
Express database currently contains signaling pathways from Kyoto Ency-
clopedia of Genes and Genomes (http://www.genome.jp/kegg/). The
Pathway-Express performed a classic enrichment analysis that was based
on a hypergeometric distribution to identify those pathways that contained
a proportion of differentially expressed genes that was significantly differ-
ent from that expressed just by chance.13
Microarray Validation by Quantitative Real-Time
Reverse Transcriptase Polymerase Chain Reaction
After the microarray analysis, selected genes were chosen for validation
by quantitative real-time reverse transcriptase polymerase chain reaction.
Gene selection was based on the magnitude of change in expression and
the relevance to skeletal muscle protein regulation. The following 5 genes
were selected: cathepsin L1 (CTSL1), F-box protein 32 (FBXO32),
myocyte enhancer factor 2C (MEF2C), superoxide dismutase 2 (SOD2),
mitochondrial and tripartite motif-containing 63 (TRIM63). The online
supplement gives details of the quantitative real-time reverse transcriptase
polymerase chain reaction procedure. Fold change values obtained from
microarray and reverse transcriptase polymerase chain reaction analysis
were compared with Pearson correlation.RESULTS
Patient Collective and Clinical Data
The patients’ demographic and clinical characteristics
are given in Table 1. The average MV duration before the
first biopsy sample was taken was 124 19 minutes; the av-
erage MV duration before the second biopsy sample was
taken was 415  112 minutes. The elapsed time between
muscle biopsies was 4.9  1.8 hours. CPB time ranged
from 159 to 266 minutes, with a mean  SD of 218  51
minutes. One of the 5 subjects did not require hypothermic
circulatory arrest because the aortic arch was replaced un-
der selective antegrade perfusion, although the body was
cooled to 18C for cerebral protection. All subjects toler-
ated surgery and both biopsies without event, and no
study-related postoperative complications were noted.Microarray Data Analysis and Biostatistics
Microarray data analysis identified 1080 probe sets that
were differentially expressed (early vs late samples,
P<.005). Among these 1080 probe sets, 779 unique known
genes were identified. Most of the transcripts (616/779,
79%) were upregulated. The pathway analysis revealed
that janus kinase/signal transducers and activators ofgery c November 2011
TABLE 1. Clinical baseline characteristics of 5 patients undergoing cardiothoracic surgery
Case
Age
(y)
Height
(cm)
Weight
(kg) Comorbidities Type of surgery
CPB time
(min)
HCA time
(min)
CP time
(min)
1 56 183 155 Tracheostomy, morbid obesity, obstructive
lung defect, decreased oxygen diffusion
capacity, obstructive sleep apnea
AVR, ascending and proximal arch aorta 243 15 202
3 76 174 87 Aortic insufficiency, CAD, chronic renal
insufficiency, hypertension, prostate
cancer with radiation, bladder disorder
with chronic UTIs, urethral strictures
AVR, ascending and proximal arch aorta 159 10 135
4 71 182 100 DeBakey type 2 aortic dissection,
hypertension, abdominal artery aneurysm,
COPD
Ascending and proximal arch aorta 166 24 42
5 54 183 110 Severe aortic insufficiency, dilated
cardiomyopathy (EF 40%), CAD
Ascending and proximal arch aorta 266 5 204
6 78 180 100 CAD, hypertension, diabetes mellitus Aortic root valve-sparing procedure 255 NA 130
Mean 67 180 110 218 13.5 142
SD 11 4 26 51 8 66
CPB, Cardiopulmonary bypass; HCA, hypothermic circulatory arrest; CP, crossclamp; AVR, aortic valve replacement; CAD, coronary artery disease; UTI, urinary tract infection;
COPD, chronic obstructive pulmonary disease; EF, ejection fraction; NA, not applicable.
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Stranscription (JAK-STAT) and p53 signaling pathways were
significantly overexpressed (P<.0001).
A NetAffx query was performed to retrieve Gene Ontol-
ogy classifications of the differently expressed genes, which
were grouped into 11 functional categories (Table E1).
Because we expected a large number of genes to be differ-
entially expressed, a priori we elected to narrow our discus-
sion to selected physiologically relevant categories,
including the stress response and redox regulation (Tables
2 and E2), protein turnover and energy metabolism
(Tables 3 and E3), and muscle-specific and neuromuscular
regulatory genes (Table 4). The remaining functional cate-
gories and the list of expressed sequence tags are summa-
rized in the online data supplement (Tables E2–E11).
In the stress response and redox regulation category, we
identified 86 differentially expressed transcripts linked to
regulation of inflammation and chemotaxis, the JAK-STAT
cascade, and redox regulation. Two inflammatory and che-
motaxis response genes, IL6 and IL8, showed the highest
fold changes at 15.6-fold and 22.7-fold, respectively. Genes
responsible for redox regulation included peroxiredoxin 6
(PRDX6, 1.9-fold), superoxide dismutase in mitochondria
(SOD2, 2.9-fold), thioredoxin (TXN, 1.9-fold), selenoprotein
S (SELE, 1.5-fold), and a number of the metallothioneins
(Table E2). Changes in redox regulation were accompanied
by a large upregulation of cell cycle genes, including a sig-
nificant overexpression of the p53 pathway.
In the protein turnover and energy metabolism category,
differentially-expressed genes were linked to lysosomal ac-
tivity, protein folding, protein synthesis, and the ubiquitin-
proteasome–dependent pathway. We found that messenger
RNAs for the ubiquitin-proteasome–dependent pathway
were upregulated, including several ubiquitin-conjugatingThe Journal of Thoracic and Carenzymes (1.5- to 1.8-fold), ubiquitin-specific peptidases
(1.8- to 2.2-fold), and 1 muscle-specific ubiquitin protein
ligase enzyme (the E3 ligase MuRF-1, gene TRIM63, 2.6-
fold). Interestingly, another well-known gene associated
with muscle atrophy, F-box protein 32 (FBXO32), also
known as MAF-box, was significantly downregulated
(Table 3). We also identified differentially expressed tran-
scripts related to carbohydrate metabolism, glucose trans-
port, and lipid metabolism (Table E3).
In the muscle-specific and neuromuscular regulatory
category, differential expressions occurred in genes linked
to sarcomere structure and function and to neuromuscular
synaptic transmission (Table 4).
Quantitative Real-Time Reverse Transcriptase
Polymerase Chain Reaction
The results from quantitative real-time reverse transcrip-
tase polymerase chain reaction showed excellent agreement
with those of the microarray. A significant correlation was
observed between gene array changes and quantitative
real-time reverse transcriptase polymerase chain reaction
(r ¼ 0.95, P<.0001).
DISCUSSION
Genome-wide gene expression profiling has enabled
scientists to investigate complex biologic processes regu-
lated at the transcriptional level. In this study, we examined
the gene expression profile of human diaphragm muscles
from 5 clinically scheduled patients who underwent CTS.
The combined effects of CPB, hypothermia, anesthesia,
fasting, and controlled MV resulted in 779 unique
transcripts that were differentially expressed (P< 0.005)
between early and late CTS periods. Diaphragm genediovascular Surgery c Volume 142, Number 5 1217
TABLE 2. List of key genes related to stress response and redox regulation that were significantly different after surgery
Probe set Symbol Fold* P value Description Function
Regulation of inflammation and chemotaxis
216598_s_at CCL2 8.2 1.2E6 Chemokine (C-C motif) ligand 2 Inflammatory response
202859_x_at IL8 22.7 1.1E3 Interleukin 8 Mediates neutrophil chemotaxis and migration
218995_s_at EDN1 1.8 3.1E3 Endothelin 1 Neutrophil chemotaxis
201925_s_at CD55 2.0 3.0E3 CD55 molecule, decay-accelerating factor for
complement (Cromer blood group)
Immune response
204908_s_at BCL3 3.9 9.9E6 B-cell chronic lymphocytic leukemia/
lymphoma 3
T-helper 1–type immune response
204748_at PTGS2 5.2 4.0E4 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
Response to cytokine stimulus
221477_s_at MGC5618 1.6 4.3E3 Hypothetical protein MGC5618 Response to oxidative stress
JAK-STAT signaling
209682_at CBLB 1.8 1.9E3 Cas-Br-M (murine) ecotropic retroviral
transforming sequence b
Regulator of JAK-STAT signaling
205207_at IL6 15.6 3.5E5 Interleukin 6 (interferon b2) Mediates leukocytosis, thrombosis, and
lymphocyte activation
1552611_a_at JAK1 1.5 4.3E3 Janus kinase 1 (a protein tyrosine kinase) Couples cytokine ligand binding to STAT
signaling
210001_s_at SOCS1 4.7 1.0E6 Suppressor of cytokine signaling 1 JAK-STAT cascade
203372_s_at SOCS2 3.1 2.7E5 Suppressor of cytokine signaling 2 JAK-STAT cascade
227697_at SOCS3 9.4 1.1E5 Suppressor of cytokine signaling 3 JAK-STAT cascade
208992_s_at STAT3 1.6 2.0E3 Signal transducer and activator of transcription
3 (acute-phase response factor)
JAK-STAT cascade
Cell cycle regulation (p53 signaling)
203725_at GADD45A 3.0 4.5E4 Growth arrest and DNA damage–inducible, a Cell cycle regulator
209305_s_at GADD45B 10.2 5.3E6 Growth arrest and DNA damage–inducible, b Cell cycle regulator
204121_at GADD45G 4.3 1.8E6 Growth arrest and DNA damage–inducible, g Cell cycle regulator
Redox regulation
242751_at PRDX6 1.9 6.3E4 Peroxiredoxin 6 Cell redox homeostasis
215223_s_at SOD2 2.9 1.1E5 Superoxide dismutase 2, mitochondrial Cell redox homeostasis
208864_s_at TXN 1.9 2.9E3 Thioredoxin Cell redox homeostasis
223209_s_at SELS 1.5 4.0E3 Selenoprotein S Cell redox homeostasis: regulated by glucose
deprivation and endoplasmic reticulum stress
217546_at MT1M 11.4 6.0E7 Metallothionein 1M Metallothioneins may inhibit reactive oxygen
species and protect against DNA damage
JAK-STAT, Janus kinase/signal transducers and activators of transcription. *Fold denotes fold change between presurgical and postsurgical conditions.
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cific pathways that included upregulation of inflammation,
redox regulation, and protein turnover genes, as well as
downregulation of some of energy metabolism, cell cycle,
and neuromuscular function genes.
Inflammatory Mediators
We found a robust and diverse expression of inflamma-
tory and stress-responsive genes in the diaphragm during
the course of CTS. The pathway analysis revealed
strongly significant overexpression of JAK-STAT signaling
(P < .0001). JAK-STAT signaling regulates cellular re-
sponses to cytokines and growth factors through binding
to IL-6, with downstream phosphorylation of 1 or more sig-
nal transducer and activator of transcription molecules. The
proinflammatory cytokine IL-6 was highly upregulated1218 The Journal of Thoracic and Cardiovascular Sur(15.6-fold), and it may be upregulated in response to ther-
mal stress as well as CPB. Significant increases of inflam-
matory gene expressions, including those for IL-6 and IL-8,
have also been reported in human intercostal muscles after
an average 74 minutes of CPB.11 Of the 32 upregulated
genes reported in the intercostals, 14 were similarly ele-
vated in the diaphragms of our patients, and a large number
of these served stress-responsive functions. It has been
hypothesized that both systematic inflammatory responses
and intrinsic oxidative stress result in impaired diaphragm
neuromuscular transmission during CPB.8 We have previ-
ously shown in patients undergoing complex cardiac
surgery that those patients with the highest circulating
levels of IL-6 and IL-10 had greater morbidity postopera-
tively, including prolonged ventilation and longer intensive
care unit stay.14gery c November 2011
TABLE 3. Expression of protein turnover and energy metabolism key genes that were significantly different in the diaphragm after surgery
Probe set Symbol Fold* P value Description Function
Thermosensitive regulatory genes
200881_s_at DNAJA1 1.9 2.9E3 DnaJ (heat shock protein 40) homolog, subfamily A,
member 1
Chaperone-mediated protein folding requiring
cofactor
201041_s_at DUSP1 3.7 8.8E4 Dual specificity phosphatase 1 Thermal sensitive mitogen-activated protein kinase
inhibitor, may inhibit cellular proliferation
Proteolysis-related genes
225647_s_at CTSC 2.7 2.1E3 Cathepsin C Lysosome
202087_s_at CTSL1 2.0 2.8E3 Cathepsin L1 Lysosome
202723_s_at FOXO1 1.9 2.0E3 Forkhead box O1 Transcriptional regulator of ubiquitin ligases
204131_s_at FOXO3 1.7 2.0E3 Forkhead box O3 Transcription factor; regulates ubiquitin ligases,
neutral factor kB signaling, and p53 activity
231990_at USP15 2.2 1.5E4 Ubiquitin specific peptidase 15 Ubiquitin thiolesterase activity
241762_at FBXO32 3.5 5.6E5 F-box protein 32 Ubiquitin-dependent protein catabolic process
236972_at TRIM63 2.6 4.1E5 Tripartite motif-containing 63 Ubiquitin-dependent protein catabolic process
243046_at UBE2D3 1.8 7.1E4 Ubiquitin-conjugating enzyme E2D 3 (UBC4/5
homolog, yeast)
Ubiquitin–protein ligase activity
202779_s_at UBE2S 1.6 1.1E3 Ubiquitin-conjugating enzyme E2S Ubiquitin–protein ligase activity
Protein translation–related genes
225954_s_at MIDN 3.4 1.3E6 Midnolin Protein modification
223481_s_at MRPL47 1.8 8.9E4 Mitochondrial ribosomal protein L47 Protein synthesis
201574_at ETF1 3.4 3.0E3 Eukaryotic translation termination factor 1 Protein synthesis
224873_s_at MRPS25 1.4 5.0E3 Mitochondrial ribosomal protein S25 Protein synthesis
Apoptosis-related genes
201101_s_at BCLAF1 3.4 3.6E3 BCL2-associated transcription factor 1 Interact with B-cell lymphoma 2–related proteins
205681_at BCL2A1 3.4 3.8E3 BCL2-related protein A1 Interact with B-cell lymphoma 2–associated X
protein isoform sigma
209189_at FOS 3.4 1.9E3 v-fos FBJ murine osteosarcoma viral oncogene
homolog
Apoptotic regulation
201473_at JUNB 3.4 2.6E5 B-jun proto-oncogene Response to cytokine stimulus; proapoptotic
transcription factor acting with FOS
Energy metabolism genes
205960_at PDK4 3.4 3.5E3 Pyruvate dehydrogenase kinase, isozyme 4 Glucose metabolism
235374_at MDH1 2.2 2.3E3 Malate dehydrogenase 1, nicotinamide adenine
dinucleotide (soluble)
Glycolysis
208383_s_at PCK1 2.3 1.3E3 Phosphoenolpyruvate carboxykinase 1 (soluble) Regulation of gluconeogenesis
*Fold denotes fold change between presurgical and postsurgical conditions.
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Oxidative stress has been implicated as a major contrib-
utor to ventilator-induced diaphragm dysfunction in ani-
mals, and significant oxidative stress occurs with as little
as 3 to 6 hours of controlled MV.15 CPB also elicits acute
oxidative stress in cardiac and skeletal myofibers, which
may contribute to post-CPB myocardial dysfunction.16 In
this study, we found that several genes responsible for atten-
uating oxidative stress were upregulated, including the en-
dogenous antioxidant genes SOD2, PRDX6, and TXN
(Table 2). Moreover, robust upregulation of metallothionein
genes can occur in response to fasting, inactivity, or re-
warming after cold exposure,2,17,18 and their transcription
may protect skeletal muscle from lipid peroxidation and
contractile dysfunction.4 In conjunction with upregulated
stress response signaling and an altered redox state, gene
expression favored cell cycle arrest. In particular, the path-The Journal of Thoracic and Carway analysis revealed overexpression of the p53 signaling
pathway, which transcriptionally inhibits cell cycle progres-
sion in the presence of DNA damage and can facilitate cell
apoptosis. Upregulation of cell cycle arrest gene expression
has been reported separately during instances of MV, CPB,
hypothermia, and fasting.4,11,17,18
Protein Turnover
MV-induced diaphragm atrophy has been linked to
significant activity of the calcium-activated, proteosomal,
and neutral factor kB pathways.15 The ubiquitin-
proteasome pathway is thought to control the majority of
myofibrillar protein breakdown during muscle wasting,19
and the E3 ubiquitin ligases MAF-box and MuRF-1 have
been implicated in animal models of inactivity15 and
inflammation-mediated disuse atrophy.20 We found
that genes for MuRf-1 and several atrophy-relateddiovascular Surgery c Volume 142, Number 5 1219
TABLE 4. List of muscle specific and neuromuscular regulatory genes that were significantly different in the diaphragm after surgery
Probe set Symbol Fold* P value Description Function
Sarcomere structure and function
215795_at MYH7B 2.4 4.3E3 Myosin, heavy chain 7B, cardiac muscle, b Actin binding
222976_s_at TPM3 1.6 3.2E3 Tropomyosin 3 Actin binding
1567107_s_at TPM4 2.1 1.0E3 Tropomyosin 4 Actin binding
1569512_at SVIL 1.9 7.5E4 Supervillin Actin filament binding
242795_at MYOT 2.8 2.5E3 Myotilin Actin filament stabilization during muscle
contraction
211926_s_at MYH9 1.7 4.4E3 Myosin, heavy chain 9, nonmuscle Actin cytoskeletal reorganization
207424_at MYF5 1.6 1.9E3 Myogenic factor 5 Myogeneic differentiation
206657_s_at MYOD1 2.0 4.0E3 Myogenic differentiation 1 Myogeneic differentiation
236395_at MEF2C 3.5 1.4E4 Myocyte enhancer factor 2C Terminal differentiation; thick filament
organization
206201_s_at MEOX2 3.5 6.1E4 Mesenchyme homeobox 2 Muscle differentiation
Synaptic transmission
200815_s_at PAFAH1B1 1.4 4.8E3 Platelet-activating factor acetylhydrolase,
isoform Ib, a subunit 45 kDa
Neuromuscular process controlling balance
204224_s_at GCH1 4.6 6.3E5 Guanosine triphosphate cyclohydrolase 1
(dopa-responsive dystonia)
Neuromuscular process controlling posture
206115_at EGR3 4.1 4.9E3 Early growth response 3 Neuromuscular synaptic transmission
206552_s_at TAC1 5.0 2.0E5 Tachykinin, precursor 1 Positive regulation of synaptic transmission,
g-aminobutyric acid–ergic
201693_s_at EGR1 6.7 2.3E3 Early growth response 1 Regulation of long-term neuronal synaptic
plasticity
210090_at ARC 10.7 1.2E5 Activity-regulated cytoskeleton-associated
protein
Regulation of neuronal synaptic plasticity
201170_s_at BHLHB2 2.7 1.3E5 Basic helix-loop-helix domain containing,
class B2
Regulation of neuronal synaptic plasticity
205249_at EGR2 6.1 3.4E3 Early growth response 2 (Krox-20 homolog,
Drosophila)
Regulation of neuronal synaptic plasticity
215483_at AKAP9 1.5 2.7E3 Kinase (PRKA) anchor protein (yotiao) 9 Synaptic transmission
241652_x_at LIN7A 2.1 2.0E3 Lin-7 homolog A (Caenorhabditis elegans) Synaptic transmission
*Fold denotes fold change between presurgical and postsurgical conditions.
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Subiquitin-conjugating enzymes (E2) were upregulated,
whereas the gene expression of MAF-box was actually
downregulated (Table 3). The FOX1 and FOXO3 transcrip-
tion factor genes, important upstream regulators of MAFbx
and MuRf-1, were upregulated. Increased expressions of
ubiquitin-proteasome–dependent pathway genes and the
gene for cathepsin L observed in our patients have also
been reported in rodents subjected to prolonged MV.21 In
addition to early activity of genes related to the ubiquitin-
proteasome–dependent pathway noted in our patients, the
apoptosis-regulating BCL2 gene was overexpressed. We
did not, however, find significant differences in downstream
proapoptotic caspase genes. These results suggest that acute
mediators of atrophy and apoptosis were rapidly activated
during CTS, and we hypothesize that longer durations of
MVare required for significant effects on downstream pro-
teolytic and apoptotic gene expressions.
Energy Metabolism
Observed changes in energy metabolism gene expression
suggest reduced energy use by the diaphragm during CTS1220 The Journal of Thoracic and Cardiovascular Sur(Table 3). Upregulation of PDK4, a negative moderator of
mitochondrial pyruvate dehydrogenase, results in decreased
mitochondrial use of glucose. Interestingly,MuRF1 directly
targets PDK4, and transcriptional facilitation of PDK4
could reflect MuRF1 transcriptional regulation of protein
synthesis, proteolysis, and preservation of the amino acid
pool.22 Expression of MDH1 was downregulated during
CTS and corresponded with other MV inactivity models.4
Decreased MDH1 expression suggests suppression of the
malate shuttle and could occur as a consequence either of
reduced energetic requirements or of a limited ability for
the mitochondria to process reduced nicotinamide adenine
dinucleotide.
Sarcomere Structure
Short periods of diaphragm inactivity during surgery
were associated with upregulation of myofilament stabiliza-
tion genes (Table 4). These structural and costameric mole-
cules may collectively act as stabilizers and force-couplers
between the sarcomere and plasma membrane, and they
may initiate cell cascades in response to altered mechanicalgery c November 2011
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genes as a response to maintain phospholipid membrane
fluidity.18 Still, limited research is available regarding the
transcriptional remodeling of the supportive proteins during
the course of CTS.
Neuromuscular Function
Eleven of the upregulated genes promoted neural plastic-
ity and synaptic transmission (Table 4). Anesthesia was in-
duced after a short infusion of neuromuscular blockade at
the onset of surgery; however, blockade was not continued
throughout the procedure. Thus baseline synaptic transmis-
sion gene expression may have been relatively depressed
relative to late surgery. Although thoracic cooling can
decrease phrenic nerve conduction and increase evoked
diaphragm latency, late surgical rewarming may have ac-
counted for the upregulation in synaptic gene expression
observed in our patients.9
In addition to differential synaptic gene expression,
myogenic-specific genes were upregulated, including
MYOD, MEOX2, and MEF2C. Coexpression of myogenic-
specific genes and cell cycle inhibitors has been seen to in-
crease acutely in other disuse atrophy models.24
Limitations
Microarrays allow simultaneous analysis of the expres-
sions of thousands of genes; however, the microarray results
for any given gene are often noisy or ambiguous.Microarrays
are potentially influenced bymany external factors, including
array production, RNA extraction methods, the probes used
for labeling, hybridization conditions, and image analysis.25
Despite the small sample size in this study, we nevertheless
found substantial changes in diaphragm gene expression
and verified the microarray results by an independent
method. Conventionally, quantitative real-time reverse tran-
scriptase polymerase chain reaction is the method of choice
for validation, because it is a sensitive, high-throughput pro-
cedure that requires a minimal amount of test material.25 The
results from quantitative real-time reverse transcriptase poly-
merase chain reaction showed excellent agreement with the
microarray analysis with respect to both direction and mag-
nitude of change (r ¼ 0.95, P<.0001).
The CTSmodel used in this study offers both benefits and
challenges. Understandably, we could not include a control
group; however, the repeated measures design enabled sub-
jects to serve as their own controls. The model was not
a pure MV inactivity paradigm; in addition to controlled
MV, it included general anesthesia, CPB, surgical repair,
hypothermia, and short-term fasting. The stressors of sur-
gery and quiescence, however, negatively impacted dia-
phragm gene expression. Recent work has shown that
neuromuscular blockade and CPB impair diaphragm con-
tractility and neuromuscular transmission independently
of the effects of MV alone.8The Journal of Thoracic and CarAlthough our patients were classified as at low preoper-
ative risk for ventilator-induced diaphragm dysfunction,
the multifactorial stressors of surgery significantly in-
creased the expression of genes implicated in inflamma-
tion, proteolysis, and cell cycle arrest. Diaphragm biopsy
specimens from patients with chronic obstructive pulmo-
nary disease illustrate that oxidative stress and proteolysis
are significantly elevated at baseline.26 Additional CTS
stressors could potentially place patients with preexisting
respiratory muscle dysfunction at greater risk for postoper-
ative weaning failure and ventilator-induced diaphragm
dysfunction.27CONCLUSIONS
This study has demonstrated that CTS results in rapid
changes in human diaphragm gene expression. We identi-
fied 779 transcripts that were differentially expressed
(P< .005) between early and late surgical samples. The
major findings are as follows: (1) Inflammatory and
stress-related genes demonstrated the largest changes, in-
cluding an overexpression of JAK-STATand p53 signaling.
(2) An increased expression of antioxidant genes occurred,
which may be a protective adaptation in response to CTS.
(3) Atrophy-related gene expression occurred rapidly in the
diaphragm. (4) Gene expression for energy metabolism
indicated a low bioenergetic state, with ongoing attempts
to conserve the glucose and amino acid pool. We speculate
that some of the messenger RNA changes seen in this study
could represent an early response to diaphragm muscle in-
activity and surgical stressors in a subject cohort with a low
risk of ventilator-induced diaphragm dysfunction. The
rapid changes that we observed in gene expression may
be relevant to understanding diaphragm plasticity during
CTS. Continued investigation is warranted with patients
who may be at increased risk for development of postsurgi-
cal respiratory muscle complications, such as those with
low bioenergetic reserves, preexisting inflammatory states,
or impaired regenerative capacity.
We thank M. Cecilia Lopez, BS, as well as Sharon Norton, MS,
for technical support of the study.References
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E-MATERIALS AND METHODS
Isolation of Total RNA
TotalRNAwas isolatedwith theRneasyTMMiniKit (Qiagen
Inc,Valencia, Calif) and processed according to themanufac-
turer’s instructions. Briefly, a portion of the costal diaphragm
(approximately 20 mg) was homogenized with Polytron ho-
mogenizer (Kinematica, Inc, Bohemia, NY) and centrifuged
at full speed for 3minutes (4C) to remove insoluble material
if necessary. The sample was added to 2 volumes of 100%
ethanol and centrifuged at 10,000g for 1 minute until the ly-
sate and ethanol were mixed. Then the sample was added to
1 volume of lysis solution.After transfer of the aqueous phase
to a new tube, RNAwas precipitated and washed twice with
500 mL to 700 mLwash solution (eg, 75% ethanol). The con-
centration and purity of the extracted RNAwas processed ac-
cording to the standard protocol. In addition, the high quality
of total RNA was determined by capillary electrophoresis
with an Agilent bioanalysis system (Bioanalyzer 2001; Agi-
lent Technologies, Inc, Santa Clara, Calif).
Hierarchic Cluster Analysis
Figure 1 shows the hierarchic cluster pattern of the hy-
bridization signal intensities of 3318 probe sets that dis-
played a coefficient of variation greater than 0.5. In the
heat map, the intensity of the color indicates relative expres-
sion for each individual gene. The intensity of the color red
indicates relative expression greater than the mean for that
individual gene, blue indicates expression less than the
mean, and thewhite indicates mean expression. The dendro-
gram of the clustering is displayed above and is used to iden-
tify similarities in expression patterns among the arrays.
Quantitative Real-Time Reverse Transcriptase
Polymerase Chain Reaction
The following genes were selected for the validation of
the microarray data in this study: cathepsin L1 (CTSL1),
F-box protein 32 (FBXO32), myocyte enhancer factor 2C
(MEF2C), superoxide dismutase 2 (SOD2), and mitochon-
drial and tripartite motif-containing 63 (TRIM63).
The expressions of b2-microglobulin (B2M) and RNA
polymerase IIa (POLR2A)were used as endogenous controls.
Total RNAwas isolated with RNAEasy total RNA isola-
tion kit from Qiagen. Nucleic acid quantification was done
on a NanoDrop ND-8000 (NanoDrop Technologies, LLC,
Wilmington, Del). Reverse transcription of total RNA (1
mg) to complementary DNAwas done with a High Capacity
cDNAReverse Transcription Kit (catalog number 4368813;
Applied Biosystems by Life Technologies Corporation,
Carlsbad, Calif). In a 0.2-mL polymerase chain reaction
tube, 103 reverse transcriptase buffer (2.0 mL), 253 (100
mmol/L) deoxynucleotide triphosphate mix (0.8 mL), 103
reverse transcriptase random primers (2.0 mL), MultiScribe
Reverse Transcriptase (2.0 mL; Applied Biosystems), and
nuclease-free water were mixed with 1 mg RNA for a total
reaction volume of 20 mL. The sample was incubated at
25C for 10 minutes, 37C for 120 minutes, and then
85C for 5 minutes in a DNA Engine Peltier thermal cycler
(Bio-Rad Laboratories, Hercules, Calif). Complementary
DNAwas stored at20 in a frost-free freezer.
All primers and probes are from Applied Biosystems
Assay-on-Demand. Probe is FAM-NFQ. Amplification for
each target (Table E12) was done in triplicate with each
sample, and a no-template control was done for each assay
mix. The expressions of b2-microglobulin (B2M) and RNA
polymerase IIa (POLR2A) were used as endogenous
controls. Amplification of complementary DNA that was di-
luted 10-fold with water was done with 2X Gene Expression
MasterMix (catalog number 4369016; Applied Biosystems).
In eachwell of anOptical 96-well Fast ThermalCycling Plate
(catalog number 4346906; Applied Biosystems) was a 20-mL
reaction containing 23 Gene Expression Master Mix (10
mL), 203 TaqMan Assay-on-Demand primer and probe
mix (1.0 mL), diluted complementary DNA (3.0 mL), and
nuclease-free water (6.0 mL). The plate was sealed with Mi-
croAmp Optical Adhesive Film (catalog number 4313663;
Applied Biosystems) The sample was incubated at 50C for
20 minutes, 9510 minutes, and then 40 cycles of 95C for
15 seconds and60Cfor 1minute in a 7900HTreal-timepoly-
merase chain reaction thermocycler (Applied Biosystems).
TABLE E1. Functional classification of 779 known genes
Functional categories Genes Upregulated
Stress response and redox regulation 86 (11.0%) 80 (93.0%)
Protein turnover and energy metabolism 51 (6.5%) 45 (88.2%)
Muscle specific and neuromuscular 20 (2.6%%) 16 (80.0%)
Transcription regulation 141 (18.1%) 99 (70.2%)
Cell differentiation. growth, and proliferation 16 (2.1%) 15 (93.8%)
Signal transduction 55 (7.1%) 46 (83.6%)
Nuclear metabolism 31 (4.0%) 28 (90.3%)
Extracellular region 137 (17.6%) 108 (78.8%)
Transporter activity 19 (2.4%) 15 (78.9%)
Binding activity 115 (14.8%) 93 (80.9%)
Miscellaneous and unknown 108 (13.9%) 71 (65.7%)
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TABLE E2. Expression of stress response and redox regulation genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
216598_s_at CCL2 8.2 1.2E6 Chemokine (C-C motif) ligand 2
204470_at CXCL1 7.4 2.6E4 Chemokine (C-X-C motif) ligand 1 (melanoma growth-stimulating activity, a)
209774_x_at CXCL2 8.3 1.9E4 Chemokine (C-X-C motif) ligand 2
207850_at CXCL3 5.1 1.9E4 Chemokine (C-X-C motif) ligand 3
202859_x_at IL8 22.7 1.1E3 Interleukin 8
220088_at C5AR1 5.1 1.3E3 Complement component 5a receptor 1
210390_s_at CCL15 1.7 1.3E3 Chemokine (C-C motif) ligand 15
823_at CX3CL1 2.7 3.8E6 Chemokine (C-X3-C motif) ligand 1
205898_at CX3CR1 2.6 3.1E3 Chemokine (C-X3-C motif) receptor 1
223454_at CXCL16 2.0 1.4E3 Chemokine (C-X-C motif) ligand 16
204420_at FOSL1 3.3 6.7E4 FOS-like antigen 1
205479_s_at PLAU 3.3 1.4E4 Plasminogen activator, urokinase
210845_s_at PLAUR 4.2 9.8E5 Plasminogen activator, urokinase receptor
218995_s_at EDN1 1.8 3.1E3 Endothelin 1
201925_s_at CD55 2.0 3.0E3 CD55 molecule, decay accelerating factor for complement (Cromer blood group)
212501_at CEBPB 2.2 6.9E5 CCAAT/enhancer binding protein (C/EBP), b
205419_at EBI2 3.7 1.0E3 Epstein–Barr virus–induced gene 2 (lymphocyte-specific G protein–coupled receptor)
1555355_a_at ETS1 3.0 1.4E3 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
206087_x_at HFE 1.7 1.7E3 Hemochromatosis
202948_at IL1R1 2.9 8.5E4 Interleukin 1 receptor, type I
205403_at IL1R2 6.8 1.9E3 Interleukin 1 receptor, type II
203574_at NFIL3 4.2 2.1E3 Nuclear factor, interleukin 3 regulated
201695_s_at NP 6.9 2.5E6 Nucleoside phosphorylase
206637_at P2RY14 2.1 2.4E3 Purinergic receptor P2Y, G-protein coupled, 14
212012_at PXDN 2.5 9.3E5 Peroxidasin homolog (Drosophila)
216834_at RGS1 10.8 1.0E4 Regulator of G-protein signaling 1
213038_at RNF19B 1.8 4.1E3 Ring finger protein 19B
202307_s_at TAP1 2.3 9.9E4 Transporter 1, adenosine triphosphate–binding cassette, subfamily B (MDR/TAP)
216920_s_at TARP 1.8 4.3E3 T-cell receptor g alternate reading frame protein
215411_s_at TRAF3IP2 1.7 6.1E4 TRAF3-interacting protein 2
200670_at XBP1 1.6 2.7E3 X-box binding protein 1
208078_s_at ZEB1 6.0 2.5E5 Zinc finger E-box binding homeobox 1
1552316_a_at GIMAP1 1.9 2.5E4 guanosine triphosphatase, IMAP family member 1
210187_at FKBP1A 2.3 3.0E3 FK506-binding protein 1A, 12 kDa
204908_s_at BCL3 3.9 9.9E6 B-cell chronic lymphocytic leukemia/lymphoma 3
221009_s_at ANGPTL4 2.6 4.6E4 Angiopoietin-like 4
200989_at HIF1A 2.6 2.4E4 Hypoxia-inducible factor 1, a subunit (basic helix-loop-helix transcription factor)
216944_s_at ITPR1 1.6 7.3E4 Inositol 1,4,5-triphosphate receptor, type 1
204622_x_at NR4A2 3.7 2.7E3 Nuclear receptor subfamily 4, group A, member 2
203400_s_at TF 1.4 4.2E3 Transferrin
209112_at CDKN1B 1.6 5.0E3 Cyclin-dependent kinase inhibitor 1B (p27, Kip1)
221031_s_at APOLD1 5.6 2.0E5 Apolipoprotein L domain containing 1
204748_at PTGS2 5.2 4.0E4 Prostaglandin–endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
221477_s_at MGC5618 1.6 4.3E3 Hypothetical protein MGC5618
205548_s_at BTG3 2.6 1.6E4 BTG family, member 3
200878_at EPAS1 1.5 3.2E3 Endothelial PAS domain protein 1
202912_at ADM 3.6 2.6E4 Adrenomedullin
209682_at CBLB 1.8 1.9E3 Cas-Br-M (murine) ecotropic retroviral transforming sequence b
223377_x_at CISH 6.8 5.0E7 Cytokine-inducible SH2-containing protein
207442_at CSF3 2.7 9.7E6 Colony-stimulating factor 3 (granulocyte)
205207_at IL6 15.6 3.5E5 Interleukin 6 (interferon, b2)
212196_at IL6ST 2.0 2.1E3 Interleukin 6 signal transducer (glycoprotein 130, oncostatin M receptor)
1552611_a_at JAK1 1.5 4.3E3 Janus kinase 1 (a protein tyrosine kinase)
202431_s_at MYC 8.0 5.2E5 v-myc myelocytomatosis viral oncogene homolog (avian)
211580_s_at PIK3R3 2.8 6.8E4 Phosphoinositide-3-kinase, regulatory subunit 3 (p55, g)
(Continued)
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TABLE E2. Continued
Probe set Symbol Fold* P value Description
209193_at PIM1 3.5 2.5E5 Pim-1 oncogene
202327_s_at PKD1 2.0 3.3E4 Polycystic kidney disease 1 (autosomal dominant)
210001_s_at SOCS1 4.7 1.0E6 Suppressor of cytokine signaling 1
203372_s_at SOCS2 3.1 2.7E5 Suppressor of cytokine signaling 2
227697_at SOCS3 9.4 1.1E5 Suppressor of cytokine signaling 3
226837_at SPRED1 2.2 2.2E3 Sprouty-related, EVH1 domain containing 1
212558_at SPRY1 1.7 2.9E3 Sprouty homolog 1, antagonist of fibroblast growth factor signaling (Drosophila)
208992_s_at STAT3 1.6 2.0E3 Signal transducer and activator of transcription 3 (acute-phase response factor)
232768_at CCNB2 1.5 2.3E3 Cyclin B2
204252_at CDK2 1.6 1.9E3 Cyclin-dependent kinase 2
202284_s_at CDKN1A 4.9 7.0E7 Cyclin-dependent kinase inhibitor 1A (p21, Cip1)
203725_at GADD45A 3.0 4.5E4 Growth arrest and DNA damage–inducible, a
209305_s_at GADD45B 10.2 5.3E6 Growth arrest and DNA damage–inducible, b
204121_at GADD45G 4.3 1.8E6 Growth arrest and DNA damage–inducible, g
204286_s_at PMAIP1 2.8 2.9E3 Phorbol-12-myristate-13-acetate–induced protein 1
202628_s_at SERPINE1 8.6 3.8E4 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
235086_at THBS1 8.2 1.5E5 Thrombospondin 1
209295_at TNFRSF10B 2.5 4.9E5 Tumor necrosis factor receptor superfamily, member 10b
238624_at NLK 1.4 4.1E3 NF kB essential modulator–like kinase
242751_at PRDX6 1.9 6.3E4 Peroxiredoxin 6
215223_s_at SOD2 2.9 1.1E5 Superoxide dismutase 2, mitochondrial
208864_s_at TXN 1.9 2.9E3 Thioredoxin
223209_s_at SELS 1.5 4.0E3 Selenoprotein S
212859_x_at MT1E 3.5 9.3E6 Metallothionein 1E
213629_x_at MT1F 3.6 4.9E5 Metallothionein 1J (pseudogene)
204745_x_at MT1G 3.5 8.1E6 Metallothionein 1G
206461_x_at MT1H 3.4 2.8E5 Metallothionein 1H
217546_at MT1M 11.4 6.0E7 Metallothionein 1M
211456_x_at MT1P2 3.2 5.2E5 Metallothionein 1 pseudogene 2
208581_x_at MT1X 3.3 8.3E5 Metallothionein 1X
212185_x_at MT2A 2.4 1.5E5 Metallothionein 2A
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E3. Expression of protein turnover and energy metabolism genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
200881_s_at DNAJA1 1.9 2.9E3 DnaJ (heat shock protein 40) homolog, subfamily A, member 1
200664_s_at DNAJB1 2.8 3.6E3 DnaJ (heat shock protein 40) homolog, subfamily B, member 1
208810_at DNAJB6 1.7 4.0E4 DnaJ (heat shock protein 40) homolog, subfamily B, member 6
201041_s_at DUSP1 3.7 8.8E4 Dual specificity phosphatase 1
218459_at TOR3A 2.0 2.2E4 Torsin family 3, member A
225647_s_at CTSC 2.7 2.1E3 Cathepsin C
202087_s_at CTSL1 2.0 2.8E3 Cathepsin L1
201502_s_at NFKBIA 3.7 1.4E6 Nuclear factor of k light polypeptide gene enhancer in B-cells inhibitor, a
223217_s_at NFKBIZ 3.9 8.1E5 Nuclear factor of k light polypeptide gene enhancer in B-cells inhibitor, z
202723_s_at FOXO1 1.9 2.0E3 Forkhead box O1
204131_s_at FOXO3 1.7 2.0E3 Forkhead box O3
236975_at USP12 1.8 7.2E4 Ubiquitin-specific peptidase 12
231990_at USP15 2.2 1.5E4 Ubiquitin-specific peptidase 15
220370_s_at USP36 1.9 2.4E4 Ubiquitin-specific peptidase 36
233327_at C6orf157 1.5 2.2E3 Chromosome 6 open reading frame 157
241762_at FBXO32 3.5 5.6E5 F-box protein 32
236972_at TRIM63 2.6 4.1E5 Tripartite motif-containing 63
243046_at UBE2D3 1.8 7.1E4 Ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast)
65521_at UBE2D4 1.5 4.2E3 Ubiquitin-conjugating enzyme E2D 4 (putative)
222435_s_at UBE2J1 1.7 2.3E4 Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)
202779_s_at UBE2S 1.6 1.1E3 Ubiquitin-conjugating enzyme E2S
225954_s_at MIDN 4.3 1.3E6 Midnolin
223481_s_at MRPL47 1.8 8.9E4 Mitochondrial ribosomal protein L47
1555878_at RPS24 2.4 1.2E4 Ribosomal protein S24
238156_at RPS6 2.4 7.6E5 Ribosomal protein S6
225827_at EIF2C2 1.7 1.5E3 Eukaryotic translation initiation factor 2C, 2
208624_s_at EIF4G1 1.6 2.0E3 Eukaryotic translation initiation factor 4 g, 1
1554309_at EIF4G3 1.9 3.9E4 Eukaryotic translation initiation factor 4 g, 3
208707_at EIF5 1.9 1.7E4 Eukaryotic translation initiation factor 5
201574_at ETF1 1.8 3.0E3 Eukaryotic translation termination factor 1
224873_s_at MRPS25 1.4 5.0E3 Mitochondrial ribosomal protein S25
224692_at PPP1R15B 2.1 9.0E5 Protein phosphatase 1, regulatory (inhibitor) subunit 15B
201101_s_at BCLAF1 1.5 3.6E3 BCL2-associated transcription factor 1
205681_at BCL2A1 11.3 3.8E3 BCL2-related protein A1
209189_at FOS 6.8 1.9E3 v-fos FBJ murine osteosarcoma viral oncogene homolog
201473_at JUNB 4.1 2.6E5 B-jun proto-oncogene
200796_s_at MCL1 3.0 4.4E6 Myeloid cell leukemia sequence 1 (BCL2-related)
202340_x_at NR4A1 3.7 2.6E3 Nuclear receptor subfamily 4, group A, member 1
209959_at NR4A3 4.6 1.1E4 Nuclear receptor subfamily 4, group A, member 3
213572_s_at SERPINB1 2.8 2.1E3 Serpin peptidase inhibitor, clade B (ovalbumin), member 1
211527_x_at VEGFA 1.8 3.9E3 Vascular endothelial growth factor A
210287_s_at FLT1 3.5 8.1E4 fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
240187_at PPP1R3C 2.8 1.3E4 Protein phosphatase 1, regulatory (inhibitor) subunit 3C
209184_s_at IRS2 2.0 3.8E4 Insulin receptor substrate 2
205960_at PDK4 4.0 3.5E3 Pyruvate dehydrogenase kinase, isozyme 4
235374_at MDH1 2.2 2.3E3 Malate dehydrogenase 1, nicotinamide adenine dinucleotide (soluble)
206932_at CH25H 8.6 1.4E5 Cholesterol 25-hydroxylase
243296_at PBEF1 5.1 3.3E4 Pre–B-cell colony-enhancing factor 1
208383_s_at PCK1 2.3 1.3E3 Phosphoenolpyruvate carboxykinase 1 (soluble)
216236_s_at SLC2A3 5.1 1.1E5 Solute carrier family 2 (facilitated glucose transporter), member 3
201195_s_at SLC7A5 2.2 1.1E3 Solute carrier family 7 (cationic amino acid transporter, yþsystem), member 5
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E4. Expression of transcript regulation genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
Negative regulation of transcription
201862_s_at LRRFIP1 2.1 2.9E3 Leucine-rich repeat (in FLII) interacting protein 1
202861_at PER1 2.5 1.5E4 Period homolog 1 (Drosophila)
203749_s_at RARA 1.9 2.5E3 Retinoic acid receptor, alpha
222815_at RNF12 2.1 9.8E4 Ring finger protein 12
202241_at TRIB1 3.3 2.0E4 Tribbles homolog 1 (Drosophila)
213183_s_at CDKN1C 1.7 5.0E3 Cyclin-dependent kinase inhibitor 1C (p57, Kip2)
227404_s_at EGR1 3.0 6.0E4 Early growth response 1
202768_at FOSB 5.2 1.2E3 FBJ murine osteosarcoma viral oncogene homolog B
237403_at GFI1B 2.2 2.3E5 Growth factor independent 1B (potential regulator of CDKN1A, translocated in CML)
203395_s_at HES1 2.8 3.0E3 Hairy and enhancer of split 1 (Drosophila)
203275_at IRF2 1.6 4.1E3 Interferon regulatory factor 2
203297_s_at JARID2 1.6 1.1E3 Jumonji, AT-rich interactive domain 2
213146_at JMJD3 4.3 2.4E4 Jumonji domain containing 3
202393_s_at KLF10 2.8 1.6E4 Kruppel-like factor 10
205932_s_at MSX1 1.9 2.3E3 msh homeobox 1
221715_at MYST3 1.7 2.2E3 MYST histone acetyltransferase (monocytic leukemia) 3
215073_s_at NR2F2 1.9 4.5E4 Nuclear receptor subfamily 2, group F, member 2
210391_at NR6A1 1.4 2.5E3 Nuclear receptor subfamily 6, group A, member 1
202600_s_at NRIP1 2.1 7.7E5 Nuclear receptor interacting protein 1
228964_at PRDM1 2.7 1.4E4 PR domain containing 1, with ZNF domain
201846_s_at RYBP 2.4 3.6E4 RING1 and YY1 binding protein
204900_x_at SAP30 1.6 2.9E3 Sin3A-associated protein, 30 kDa
203313_s_at TGIF1 4.1 1.7E4 Transforming growth factor b–induced factor homeobox 1
213138_at ARID5A 2.2 2.1E3 AT-rich interactive domain 5A (MRF1-like)
1558000_at ARID5B 3.1 2.4E5 AT-rich interactive domain 5B (MRF1-like)
201277_s_at HNRPAB 1.9 2.7E3 Heterogeneous nuclear ribonucleoprotein A/B
208930_s_at ILF3 1.4 4.6E3 Interleukin enhancer binding factor 3, 90 kDa
221841_s_at KLF4 3.1 3.1E4 Kruppel-like factor 4 (gut)
223467_at RASD1 5.7 3.1E5 RAS, dexamethasone-induced 1
Positive regulation of transcription
205290_s_at BMP2 3.8 2.0E5 Bone morphogenetic protein 2
200033_at DDX5 1.8 3.0E4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 5
1567013_at NFE2L2 1.9 9.2E4 Nuclear factor (erythroid-derived 2)–like 2
211951_at NOLC1 2.0 7.5E4 Nucleolar and coiled-body phosphoprotein 1
223394_at SERTAD1 3.0 1.7E3 SERTA domain containing 1
206170_at ADRB2 1.8 3.3E3 Adrenergic, beta-2-, receptor, surface
225557_at AXUD1 6.4 8.9E5 AXIN1 upregulated 1
204093_at CCNH 1.7 3.0E4 Cyclin H
212418_at ELF1 1.8 3.4E3 E74-like factor 1 (ets domain transcription factor)
1553613_s_at FOXC1 2.6 4.6E5 Forkhead box C1
202531_at IRF1 4.5 2.6E4 Interferon regulatory factor 1
224606_at KLF6 2.8 8.5E6 Kruppel-like factor 6
209348_s_at MAF 1.7 3.2E3 v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
218559_s_at MAFB 2.6 1.1E4 v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)
205135_s_at NUFIP1 1.9 8.8E4 Nuclear fragile X mental retardation protein interacting protein 1
236557_at ZBTB38 1.6 1.7E3 Zinc finger and BTB domain containing 38
201329_s_at ETS2 4.9 1.8E5 v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
200750_s_at RAN 1.5 2.5E3 RAN, member RAS oncogene family
206036_s_at REL 1.8 1.6E3 v-rel reticuloendotheliosis viral oncogene homolog (avian)
Regulation of transcription
213198_at ACVR1B 1.7 3.3E4 Activin A receptor, type IB
203322_at ADNP2 1.6 9.8E4 ADNP homeobox 2
1560765_a_at ARHGAP22 1.9 6.3E4 Rho guanosine triphosphatase activating protein 22
244519_at ASXL1 1.7 9.7E4 Additional sex combs–like 1 (Drosophila)
(Continued)
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TABLE E4. Continued
Probe set Symbol Fold* P value Description
204194_at BACH1 1.9 1.3E3 BTB and CNC homology 1, basic leucine zipper transcription factor 1
1559975_at BTG1 2.3 3.1E4 B-cell translocation gene 1, antiproliferative
201235_s_at BTG2 6.0 4.5E4 BTG family, member 2
200777_s_at BZW1 1.6 1.1E3 Basic leucine zipper and W2 domains 1
1555411_a_at CCNL1 4.2 1.7E6 Cyclin L1
213006_at CEBPD 5.0 1.0E6 CCAAT/enhancer binding protein (C/EBP), d
207630_s_at CREM 3.3 3.0E5 Cyclic adenosine monophosphate–responsive element modulator
224654_at DDX21 2.9 7.7E4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21
202776_at DNTTIP2 1.8 3.9E3 Deoxynucleotidyltransferase, terminal, interacting protein 2
226952_at EAF1 1.5 2.7E3 ELL-associated factor 1
226099_at ELL2 7.3 3.2E5 Elongation factor, RNA polymerase II, 2
203643_at ERF 1.5 4.2E3 Ets2 repressor factor
1561167_at ETV6 2.1 5.3E4 Ets variant gene 6 (TEL oncogene)
241824_at FOSL2 2.3 5.2E4 FOS-like antigen 2
218458_at GMCL1 1.6 2.2E3 Germ cell–less homolog 1 (Drosophila)
222830_at GRHL1 2.3 2.5E4 Grainyhead-like 1 (Drosophila)
208066_s_at GTF2B 1.6 1.8E3 General transcription factor IIB
213844_at HOXA5 2.0 1.7E3 Homeobox A5
205453_at HOXB2 1.6 9.9E4 Homeobox B2
228904_at HOXB3 1.7 2.4E3 Homeobox B3
229732_at HSZFP36 1.9 4.1E4 ZFP36 for a zinc finger protein
1557174_a_at IRAK1BP1 2.0 8.0E4 Interleukin 1 receptor–associated kinase 1 binding protein 1
224569_s_at IRF2BP2 1.5 3.0E3 Interferon regulatory factor 2 binding protein 2
224933_s_at JMJD1C 2.1 2.7E3 Jumonji domain containing 1C
212723_at JMJD6 2.1 4.6E4 Jumonji domain containing 6
222728_s_at JOSD3 1.8 1.0E3 Josephin domain containing 3
Regulation of transcription
208989_s_at KDM2A 1.5 3.6E3 F-box and leucine-rich repeat protein 11
1556060_a_at KIAA1702 1.8 1.7E3 KIAA1702 protein
203542_s_at KLF9 2.6 4.7E5 Kruppel-like factor 9
200704_at LITAF 3.2 2.8E3 Lipopolysaccharide-induced tumor necrosis factor
200776_s_at LOC151579 2.0 5.5E4 Similar to basic leucine zipper and W2 domains 1
244818_at LOC390933 1.8 4.4E3 Similar to hypothetical protein
36711_at MAFF 8.7 4.0E7 v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
226206_at MAFK 1.5 2.2E3 v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)
227538_at MED26 1.6 2.3E3 Mediator complex subunit 26
1552330_at MGC16385 1.6 7.5E4 Hypothetical protein MGC16385
225344_at NCOA7 1.9 4.9E3 Nuclear receptor coactivator 7
210162_s_at NFATC1 1.5 3.4E3 Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1
241797_at NFIX 1.5 3.2E3 Nuclear factor I/X (CCAAT-binding transcription factor)
209706_at NKX3-1 1.7 1.0E3 NK3 homeobox 1
205251_at PER2 1.9 2.9E3 Period homolog 2 (Drosophila)
209034_at PNRC1 1.8 1.9E3 Proline-rich nuclear receptor coactivator 1
215281_x_at POGZ 1.5 2.3E3 Pogo transposable element with ZNF domain
203737_s_at PPRC1 3.3 2.0E5 Peroxisome proliferator-activated receptor g, coactivator-related 1
208965_s_at PYHIN1 3.0 8.8E4 Pyrin and HIN domain family, member 1
201586_s_at SFPQ 2.5 6.4E4 Splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated)
220358_at SNFT 1.5 2.2E3 Jun dimerization protein p21SNFT
219993_at SOX17 4.1 3.2E4 SRY (sex determining region Y)–box 17
221213_s_at SUHW4 2.1 4.7E3 Suppressor of hairy wing homolog 4 (Drosophila)
1554415_at TAF5L 1.9 6.7E4 TAF5-like RNA polymerase II, p300/CBPassociated factor (PCAF)associated factor, 65 kDa
238346_s_at TGS1 1.6 3.1E3 Trimethylguanosine synthase homolog (Saccharomyces cerevisiae)
229983_at TIGD2 1.6 1.9E3 Tigger transposable element derived 2
215111_s_at TSC22D1 1.6 2.7E3 TSC22 domain family, member 1
(Continued)
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TABLE E4. Continued
Probe set Symbol Fold* P value Description
Regulation of transcription
1554036_at ZBTB24 2.3 3.6E4 Zinc finger and BTB domain containing 24
227162_at ZBTB26 1.6 3.0E3 Zinc finger and BTB domain containing 26
206098_at ZBTB6 1.5 1.6E3 Zinc finger and BTB domain containing 6
207090_x_at ZFP30 1.5 3.9E3 Zinc finger protein 30 homolog (mouse)
216960_s_at ZNF133 1.4 4.3E3 Zinc finger protein 133
219854_at ZNF14 1.5 3.2E3 Zinc finger protein 14
206314_at ZNF167 1.9 3.4E4 Zinc finger protein 167
219495_s_at ZNF180 1.6 7.4E4 Zinc finger protein 180
213218_at ZNF187 1.6 6.5E4 Zinc finger protein 187
233461_x_at ZNF226 1.6 1.3E3 Zinc finger protein 226
242919_at ZNF253 1.8 1.6E3 Zinc finger protein 253
1558700_s_at ZNF260 1.9 3.2E4 Zinc finger protein 260
1562991_at ZNF292 1.9 4.5E4 Zinc finger protein 292
233952_s_at ZNF295 2.5 2.6E4 Zinc finger protein 295
227613_at ZNF331 3.6 4.3E4 Zinc finger protein 331
228927_at ZNF397 1.6 8.0E4 Zinc finger protein 397
209944_at ZNF410 1.6 3.3E3 Zinc finger protein 410
205514_at ZNF415 1.6 3.2E3 Zinc finger protein 415
1562211_a_at ZNF491 1.7 1.3E3 Zinc finger protein 491
1553957_at ZNF564 1.8 6.7E4 Zinc finger protein 564
1553696_s_at ZNF569 1.8 3.4E3 Zinc finger protein 569
217627_at ZNF573 1.6 3.3E3 Zinc finger protein 573
235690_at ZNF594 1.7 3.7E3 Zinc finger protein 594
239007_at ZNF616 1.6 5.0E3 Zinc finger protein 616
206188_at ZNF623 1.8 3.0E3 Zinc finger protein 623
232272_at ZNF624 1.9 1.4E3 Zinc finger protein 624
224492_s_at ZNF627 1.7 2.6E3 Zinc finger protein 627
231950_at ZNF658 2.1 2.5E3 Zinc finger protein 658
232563_at ZNF684 1.5 2.2E3 Zinc finger protein 684
1554770_x_at ZNF785 1.8 3.2E3 Zinc finger protein 785
235170_at ZNF92 1.5 2.0E3 Zinc finger protein 92
204258_at CHD1 2.8 2.7E4 Zhromodomain helicase DNA-binding protein 1
218880_at FOSL2 3.3 2.1E6 FOS-like antigen 2
219351_at TRAPPC2 1.7 4.2E3 Trafficking protein particle complex 2
204094_s_at TSC22D2 2.2 1.2E3 TSC22 domain family, member 2
200828_s_at ZNF207 1.5 2.2E3 Zinc finger protein 207
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E5. Expression of cell proliferation, growth, and differentiation genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
Cell growth
213895_at EMP1 3.8 1.5E5 Epithelial membrane protein 1
218088_s_at RRAGC 1.6 2.0E3 Ras-related guanosine triphosphate–binding C
232541_at EGFR 2.3 1.5E4 Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
Negative regulation of cell growth
212099_at RHOB 3.0 1.3E5 ras homolog gene family, member B
203120_at TP53BP2 1.8 4.8E3 Tumor protein p53 binding protein, 2
1555608_at CAPRIN2 1.7 8.6E4 Caprin family member 2
239648_at DCUN1D3 2.4 4.1E5 DCN1, defective in cullin neddylation 1, domain containing 3 (Saccharomyces cerevisiae)
Positive regulation of cell growth
205302_at IGFBP1 1.6 4.4E3 Insulin-like growth factor binding protein 1
Regulation of cell cycle
203625_x_at SKP2 1.8 6.9E4 S-phase kinase-associated protein 2 (p45)
202286_s_at TACSTD2 2.6 6.8E4 Tumor-associated calcium signal transducer 2
217523_at CD44 2.9 5.0E4 CD44 molecule (Indian blood group)
Regulation of cell growth
209101_at CTGF 2.8 1.7E5 Connective tissue growth factor
209074_s_at FAM107A 3.4 1.7E5 Family with sequence similarity 107, member A
201830_s_at NET1 3.0 4.6E4 Neuroepithelial cell transforming gene 1
233223_at NEDD9 1.7 5.1E4 Neural precursor cell expressed, developmentally downregulated 9
Enhances DNA synthesis and may play a role in cell proliferation
228266_s_at HDGFRP3 1.9 2.3E4 Hepatoma-derived growth factor, related protein 3
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E6. Expression of signal transduction genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
Cell surface receptor linked signal transduction
240221_at CSNK1A1 1.6 4.2E3 Casein kinase 1, a 1
212951_at GPR116 1.5 4.0E3 G-protein–coupled receptor 116
212070_at GPR56 2.0 1.8E3 G-protein–coupled receptor 56
204597_x_at STC1 7.8 2.5E4 Stanniocalcin 1
Negative regulation of Rho protein signal transduction
210762_s_at DLC1 1.8 9.2E4 Deleted in liver cancer 1
209324_s_at RGS16 4.5 2.2E4 Regulator of G-protein signaling 16
202388_at RGS2 5.4 1.4E4 Regulator of G-protein signaling 2, 24 kDa
224390_s_at RGS8 1.9 3.6E3 Regulator of G-protein signaling 8
223169_s_at RHOU 2.8 3.9E5 Ras homolog gene family, member U
Rac protein signal transduction
201461_s_at MAPKAPK2 1.6 1.6E3 Mitogen-activated protein kinase–activated protein kinase 2
209050_s_at RALGDS 2.0 1.3E4 Ral guanine nucleotide dissociation stimulator
226122_at PLEKHG1 2.7 7.5E5 Pleckstrin homology domain containing, family G (with RhoGef domain) member 1
Regulation of signal transduction
227481_at CNKSR3 2.2 8.3E5 CNKSR family member 3
214721_x_at CDC42EP4 2.6 8.2E6 CDC42 effector protein (Rho guanosine triphosphatase binding) 4
1555730_a_at CFL1 1.6 1.6E3 Cofilin 1 (nonmuscle)
229218_at COL1A2 2.2 3.3E3 Collagen, type I, alpha 2
212935_at MCF2L 2.0 4.2E3 MCF.2 cell line-derived transforming sequence–like
Signal transduction
231907_at ABL2 2.0 2.3E3 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)
210517_s_at AKAP12 2.4 4.6E3 A kinase (PRKA) anchor protein (gravin) 12
228176_at C9orf47 2.8 2.1E4 Chromosome 9 open reading frame 47
Rho protein signal transduction
209287_s_at CDC42EP3 1.5 3.0E3 CDC42 effector protein (Rho guanosine triphosphatase binding) 3
218157_x_at CDC42SE1 2.2 1.3E3 CDC42 small effector 1
203104_at CSF1R 1.8 1.4E3 Colony-stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms)
oncogene homolog
207945_s_at CSNK1D 2.4 5.9E4 Casein kinase 1, delta
208335_s_at DARC 2.7 1.7E4 Duffy blood group, chemokine receptor
227692_at GNAI1 1.7 1.4E3 Guanine nucleotide binding protein (G protein), a inhibiting activity polypeptide 1
223620_at GPR34 2.3 3.7E4 G-protein–coupled receptor 34
228263_at GRASP 2.2 4.6E5 GRP1 (general receptor for phosphoinositides 1)–associated scaffold protein
233953_at GUCA1C 2.1 9.6E4 Guanylate cyclase activator 1C
211676_s_at IFNGR1 1.9 3.4E4 Interferon g receptor 1
230550_at MS4A6A 1.7 1.2E3 Membrane-spanning 4-domains, subfamily A, member 6A
202149_at NEDD9 2.3 7.3E4 Neural precursor cell expressed, developmentally downregulated 9
207075_at NLRP3 2.4 1.3E3 NLR family, pyrin domain containing 3
217302_at OR2F2 1.5 4.3E3 Olfactory receptor, family 2, subfamily F, member 2
203708_at PDE4B 2.6 3.5E4 Phosphodiesterase 4B, cyclic adenosinemonophosphate–specific (phosphodiesterase E4 dunce
homolog, Drosophila)
238419_at PHLDB2 2.0 1.3E4 Pleckstrin homology–like domain, family B, member 2
219155_at PITPNC1 2.2 2.0E3 Phosphatidylinositol transfer protein, cytoplasmic 1
215894_at PTGDR 1.6 3.4E3 Prostaglandin D2 receptor (DP)
202716_at PTPN1 2.2 3.4E3 Protein tyrosine phosphatase, nonreceptor type 1
208370_s_at RCAN1 1.7 9.6E4 Regulator of calcineurin 1
209941_at RIPK1 1.9 1.3E3 Receptor (TNFRSF)–interacting serine–threonine kinase-1
209723_at SERPINB9 2.0 1.7E3 Serpin peptidase inhibitor, clade B (ovalbumin), member 9
214597_at SSTR2 1.5 4.6E3 Somatostatin receptor 2
206026_s_at TNFAIP6 4.1 8.6E5 Tumor necrosis factor a–induced protein 6
227345_at TNFRSF10D 2.9 2.9E5 Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
224553_s_at TNFRSF18 1.6 2.8E3 Tumor necrosis factor receptor superfamily, member 18
202871_at TRAF4 1.5 2.5E3 Tumor necrosis factor receptor–associated factor 4
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TABLE E6. Continued
Probe set Symbol Fold* P value Description
213476_x_at TUBB3 1.7 9.3E4 Tubulin, b 3
213425_at WNT5A 2.0 6.6E4 Wingless-type MMTV integration site family, member 5A
200641_s_at YWHAZ 1.5 1.7E3 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, z polypeptide
Small guanosine triphosphatase–mediated signal transduction
203586_s_at ARL4D 1.6 1.1E3 adenosine diphosphate ribosylation factor–like 4D
242727_at ARL5B 1.5 2.8E3 adenosine diphosphate ribosylation factor–like 5B
219622_at RAB20 1.9 5.9E4 RAB20, member RAS oncogene family
221014_s_at RAB33B 1.6 2.7E3 RAB33B, member RAS oncogene family
212724_at RND3 3.7 2.5E6 Rho family guanosine triphosphatase 3
*Fold denotes fold change between presurgical and postsurgical conditions.
TABLE E7. Expression of nuclei metabolism genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
DNA replication
204510_at CDC7 1.9 1.1E4 Cell division cycle 7 homolog (Saccharomyces cerevisiae)
201970_s_at NASP 1.7 8.8E4 Nuclear autoantigenic sperm protein (histone-binding)
238992_at POLI 2.1 4.9E4 Polymerase (DNA-directed) i
207266_x_at RBMS1 1.5 3.1E3 RNA-binding motif, single-stranded interacting protein 1
208900_s_at TOP1 2.3 8.6E4 Topoisomerase (DNA) I
Messenger RNA processing
226153_s_at CNOT6L 1.5 2.7E3 CCR4-NOT transcription complex, subunit 6–like
201055_s_at HNRNPA0 1.7 2.5E3 Heterogeneous nuclear ribonucleoprotein A0
212028_at RBM25 1.6 1.4E3 RNA-binding motif protein 25
Positive regulation of DNA replication
205239_at AREG 5.7 2.9E3 Amphiregulin (schwannoma-derived growth factor)
218718_at PDGFC 1.6 4.2E3 Platelet-derived growth factor C
RNA splicing
201386_s_at DHX15 1.6 3.2E3 DEAH (Asp-Glu-Ala-His) box polypeptide 15
201303_at EIF4A3 2.1 8.4E5 Eukaryotic translation initiation factor 4A, isoform 3
227110_at HNRNPC 1.5 4.6E3 Heterogeneous nuclear ribonucleoprotein C (C1/C2)
201376_s_at HNRPF 1.6 2.3E3 Heterogeneous nuclear ribonucleoprotein F
244235_at IVNS1ABP 4.8 3.7E5 Influenza virus NS1A binding protein
222040_at LOC728844 1.6 8.7E4 Hypothetical protein LOC728844
202189_x_at PTBP1 2.0 8.8E4 Polypyrimidine tract–binding protein 1
222443_s_at RBM8A 1.8 4.0E4 RNA-binding motif protein 8A
201070_x_at SF3B1 1.5 1.8E3 Splicing factor 3b, subunit 1, 155 kDa
200892_s_at SFRS10 1.8 5.6E4 Splicing factor, arginine/serine-rich 10 (transformer 2 homolog, Drosophila)
200754_x_at SFRS2 1.6 3.3E3 Splicing factor, arginine/serine-rich 2
206108_s_at SFRS6 1.6 1.1E3 Splicing factor, arginine/serine-rich 6
213649_at SFRS7 1.6 1.6E3 Splicing factor, arginine/serine-rich 7, 35k Da
213175_s_at SNRPB 1.6 2.1E3 Small nuclear ribonucleoprotein polypeptides B and B1
209024_s_at SYNCRIP 1.8 5.0E4 Synaptotagmin-binding, cytoplasmic RNA–interacting protein
202750_s_at TFIP11 2.3 1.6E3 Tuftelin-interacting protein 11
222748_s_at TXNL4B 1.9 5.4E4 Thioredoxin-like 4B
229630_s_at WTAP 2.5 5.4E4 Wilms tumor 1–associated protein
234295_at DBR1 1.7 7.9E4 Debranching enzyme homolog 1 (S cerevisiae)
Ribosomal RNA processing
201478_s_at DKC1 1.8 1.0E3 Dyskeratosis congenita 1, dyskerin
212422_at PDCD11 1.6 4.1E3 Programmed cell death 11
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E8. Expression of extracellular component genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
Cell junction
1553764_a_at JUB 1.8 1.4E3 Jub, ajuba homolog (Xenopus laevis)
214212_x_at PLEKHC1 1.7 1.1E3 Pleckstrin homology domain containing, family C (with FERM domain) member 1
Extracellular matrix
222162_s_at ADAMTS1 4.1 1.5E5 ADAM metallopeptidase with thrombospondin type 1 motif, 1
221541_at CRISPLD2 2.8 2.8E5 Cysteine-rich secretory protein LCCL domain containing 2
228190_at ATG4C 1.8 4.5E3 ATG4 autophagy-related 4 homolog C (Saccharomyces cerevisiae)
201883_s_at B4GALT1 1.9 2.7E4 UDP-Gal:bGlcNAc b 1,4- galactosyltransferase, polypeptide 1
229900_at CD109 2.0 2.4E4 CD109 molecule
219522_at FJX1 2.4 1.6E3 Four-jointed box 1 (Drosophila)
238018_at hCG_1990170 5.0 2.0E7 Hypothetical protein LOC285016
205258_at INHBB 4.3 2.2E3 Inhibin, b B
226977_at LOC492311 1.6 3.9E3 Similar to bovine IgA regulatory protein
225955_at LOC653506 3.0 5.4E5 Similar to meteorin, glial cell differentiation regulator–like
204575_s_at MMP19 3.2 4.4E3 Matrix metallopeptidase 19
206157_at PTX3 20.5 9.0E5 Pentraxin-related gene, rapidly induced by IL-1b
236953_s_at RP11-50D16.3 2.4 2.7E3 Similar to RIKEN complementary DNA 8030451K01
236947_at SEMA3C 1.7 1.0E3 Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
202376_at SERPINA3 5.8 1.0E5 Serpin peptidase inhibitor, clade A (a-1 antiproteinase, antitrypsin), member 3
201858_s_at SRGN 4.2 1.2E3 Serglycin
230746_s_at STC1 7.6 3.1E4 Stanniocalcin 1
241557_x_at TMEFF2 1.7 3.9E3 Transmembrane protein with endothelial growth factor–like and 2 follistatin-like domains 2
220975_s_at C1QTNF1 2.0 1.6E4 C1q and tumor necrosis factor–related protein 1
203592_s_at FSTL3 1.6 1.2E3 Follistatin-like 3 (secreted glycoprotein)
202638_s_at ICAM1 3.4 1.4E4 Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
210732_s_at LGALS8 1.8 9.4E4 Lectin, galactoside-binding, soluble, 8 (galectin 8)
Integral to membrane
220948_s_at ATP1A1 2.0 2.8E4 Adenosine triphosphatase, Naþ/Kþ transporting, a 1 polypeptide
208836_at ATP1B3 2.8 5.7E5 Adenosine triphosphatase, Naþ/Kþ transporting, b 3 polypeptide
225612_s_at B3GNT5 5.4 1.9E5 UDP-GlcNAc:bGal b-1,3-N-acetylglucosaminyltransferase 5
221484_at B4GALT5 1.9 6.3E4 UDP-Gal:bGlcNAc b 1,4- galactosyltransferase, polypeptide 5
202710_at BET1 1.8 1.5E3 BET1 homolog (S cerevisiae)
227188_at C21orf63 2.5 1.5E4 Chromosome 21 open reading frame 63
202877_s_at CD93 2.7 9.2E4 CD93 molecule
203044_at CHSY1 3.9 1.8E5 Carbohydrate (chondroitin) synthase 1
202437_s_at CYP1B1 1.9 3.8E3 Cytochrome P-450, family 1, subfamily B, polypeptide 1
226402_at CYP2U1 1.6 4.7E3 Cytochrome P-450, family 2, subfamily U, polypeptide 1
216513_at DCT 3.0 3.1E5 Dopachrome tautomerase (dopachrome d-isomerase, tyrosine-related protein 2)
212856_at DIP 1.6 3.4E3 Death-inducing protein
230568_x_at DLL3 1.6 2.6E3 d-like 3 (Drosophila)
238500_at EMP2 1.5 4.1E3 Epithelial membrane protein 2
232024_at GIMAP2 2.7 5.9E4 Guanosine triphosphatase, IMAP family member 2
225424_at GPAM 2.1 1.7E3 Glycerol-3-phosphate acyltransferase, mitochondrial
225222_at HIAT1 1.7 1.4E3 Hippocampus abundant transcript 1
227361_at HS3ST3B1 2.0 1.2E3 Heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1
201631_s_at IER3 3.6 8.6E4 Immediate early response 3
201626_at INSIG1 2.7 3.4E3 Insulin-induced gene 1
206765_at KCNJ2 2.1 9.4E4 Potassium inwardly rectifying channel, subfamily J, member 2
205303_at KCNJ8 1.7 4.3E4 Potassium inwardly rectifying channel, subfamily J, member 8
202181_at KIAA0247 1.8 6.2E4 KIAA0247
205150_s_at KIAA0644 1.7 3.2E3 KIAA0644 gene product
239946_at KIAA0922 1.6 2.2E3 KIAA0922
242762_s_at KIAA1946 2.0 3.1E4 KIAA1946
202068_s_at LDLR 5.3 1.1E6 Low-density lipoprotein receptor (familial hypercholesterolemia)
228762_at LFNG 2.0 7.0E4 LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
(Continued)
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TABLE E8. Continued
Probe set Symbol Fold* P value Description
222231_s_at LRRC59 2.0 1.0E3 Leucine-rich repeat containing 59
224624_at LRRC8A 1.8 3.2E3 Leucine-rich repeat containing 8 family, member A
219003_s_at MANEA 1.5 2.9E3 Mannosidase, endo-a
229531_at MCART6 1.5 2.8E3 Mitochondrial carrier triple repeat 6
228282_at MFSD8 1.7 4.4E3 Major facilitator superfamily domain containing 8
1569136_at MGAT4A 2.3 7.1E4 Mannosyl (a-1,3-)-glycoprotein b-1,4-N-acetylglucosaminyltransferase, isozyme A
203780_at MPZL2 2.3 1.6E3 Myelin protein zero–like 2
223276_at MST150 2.7 2.7E4 MSTP150
224920_x_at MYADM 1.7 3.5E3 Myeloid-associated differentiation marker
1564746_at NHEDC2 1.5 4.6E3 Naþ/Hþ exchanger domain containing 2
225975_at PCDH18 2.3 6.1E4 Protocadherin 18
205077_s_at PIGF 1.5 3.4E3 Phosphatidylinositol glycan anchor biosynthesis, class F
51146_at PIGV 1.8 4.2E3 Phosphatidylinositol glycan anchor biosynthesis, class V
202446_s_at PLSCR1 3.3 6.3E5 Phospholipid scramblase 1
1569641_at PQLC1 1.5 2.6E3 PQ loop repeat containing 1
226021_at RDH10 2.8 1.4E4 Retinol dehydrogenase 10 (all trans)
219897_at RNF122 1.6 3.1E3 Ring finger protein 122
226104_at RNF170 1.7 3.4E3 Ring finger protein 170
229199_at SCN9A 1.8 3.4E3 Sodium channel, voltage-gated, type IX, alpha subunit
206211_at SELE 6.0 3.5E5 Selectin E (endothelial adhesion molecule 1)
205856_at SLC14A1 2.4 6.5E4 Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
209681_at SLC19A2 3.3 5.9E5 Solute carrier family 19 (thiamine transporter), member 2
205896_at SLC22A4 3.6 2.3E5 Solute carrier family 22 (organic cation transporter), member 4
221662_s_at SLC22A7 1.7 9.0E4 Solute carrier family 22 (organic anion transporter), member 7
225212_at SLC25A25 3.8 1.3E5 Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25
221020_s_at SLC25A32 1.8 1.8E3 Solute carrier family 25, member 32
32091_at SLC25A44 1.7 1.5E3 Solute carrier family 25, member 44
222088_s_at SLC2A14 3.9 4.2E6 Solute carrier family 2 (facilitated glucose transporter), member 14
223044_at SLC40A1 1.7 1.5E3 Solute carrier family 40 (iron-regulated transporter), member 1
219911_s_at SLCO4A1 3.0 6.2E5 Solute carrier organic anion transporter family, member 4A1
221561_at SOAT1 2.0 3.6E3 Sterol O-acyltransferase (acylcoenzyme A: cholesterol acyltransferase) 1
212470_at SPAG9 1.5 2.9E3 Sperm-associated antigen 9
203127_s_at SPTLC2 1.7 4.5E3 Serine palmitoyltransferase, long chain base subunit 2
212112_s_at STX12 1.7 9.6E4 Syntaxin 12
226489_at TMCC3 1.7 1.2E3 Transmembrane and coiled-coil domain family 3
226825_s_at TMEM165 2.0 2.2E4 Transmembrane protein 165
219253_at TMEM185B 1.6 8.8E4 Transmembrane protein 185B
218113_at TMEM2 3.3 7.5E5 Transmembrane protein 2
231697_s_at TMEM49 2.3 3.5E3 Transmembrane protein 49
1557520_a_at TMEM59 1.5 3.4E3 Transmembrane protein 59
219449_s_at TMEM70 1.5 3.4E3 Transmembrane protein 70
223772_s_at TMEM87A 1.8 3.3E3 Transmembrane protein 87A
204881_s_at UGCG 5.0 5.1E6 UDP-glucose ceramide glucosyltransferase
224953_at YIPF5 1.6 4.2E3 Yip1 domain family, member 5
222451_s_at ZDHHC9 2.2 1.7E3 Zinc finger, DHHC-type containing 9
209186_at ATP2A2 1.9 8.3E4 Adenosine triphosphatase, Ca2þ transporting, cardiac muscle, slow twitch 2
202669_s_at EFNB2 1.6 1.7E3 Ephrin-B2
204359_at FLRT2 2.1 4.0E4 Fibronectin leucine-rich transmembrane protein 2
222853_at FLRT3 2.6 2.8E3 Fibronectin leucine rich transmembrane protein 3
207316_at HAS1 3.8 6.0E5 Hyaluronan synthase 1
206432_at HAS2 4.5 3.4E5 Hyaluronan synthase 2
213620_s_at ICAM2 1.8 7.2E4 Intercellular adhesion molecule 2
203835_at LRRC32 2.0 1.3E4 Leucine-rich repeat containing 32
230494_at SLC20A1 2.6 7.6E6 Solute carrier family 20 (phosphate transporter), member 1
243166_at SLC30A5 1.5 2.9E3 Solute carrier family 30 (zinc transporter), member 5
(Continued)
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TABLE E8. Continued
Probe set Symbol Fold* P value Description
209387_s_at TM4SF1 2.3 4.1E3 Transmembrane 4 L six family member 1
Plasma membrane
209122_at ADFP 1.9 3.3E3 Adipose differentiation–related protein
227439_at ANKS1B 1.8 3.9E3 Ankyrin repeat and sterile alpha motif domain containing 1B
208536_s_at BCL2L11 1.5 3.7E3 BCL2-like 11 (apoptosis facilitator)
204995_at CDK5R1 1.6 3.0E3 Cyclin-dependent kinase 5, regulatory subunit 1 (p35)
217291_at CEACAM5 1.5 3.0E3 Carcinoembryonic antigen–related cell adhesion molecule 5
219492_at CHIC2 1.8 2.1E3 Cysteine-rich hydrophobic domain 2
1559258_a_at CXorf61 1.6 4.4E3 Chromosome X open reading frame 61
212515_s_at DDX3X 1.8 8.5E4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked
205000_at DDX3Y 2.0 3.3E4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked
1558511_s_at FAM62B 1.6 2.0E3 Family with sequence similarity 62 (C2 domain containing) member B
225582_at KIAA1754 3.7 3.8E5 KIAA1754
212086_x_at LMNA 1.9 4.5E3 Lamin A/C
202760_s_at PALM2-AKAP2 2.1 2.8E-03 PALM2-AKAP2 protein
204715_at PANX1 1.9 3.9E3 Pannexin 1
214827_at PARD6B 1.8 3.7E4 Par-6 partitioning defective 6 homolog b (Caenorhabditis elegans)
209355_s_at PPAP2B 2.1 9.4E4 Phosphatidic acid phosphatase type 2B
226430_at RELL1 1.6 3.0E3 RELT-like 1
241771_at RIMBP2 1.9 3.8E3 RIMS binding protein 2
201739_at SGK 2.2 1.1E3 Serum/glucocorticoid-regulated kinase
212110_at SLC39A14 4.1 1.2E4 Solute carrier family 39 (zinc transporter), member 14
221752_at SSH1 1.5 3.0E3 Slingshot homolog 1 (Drosophila)
225987_at STEAP4 1.9 1.8E3 STEAP family member 4
201060_x_at STOM 2.3 3.4E4 Stomatin
235670_at STX11 2.5 1.7E4 Syntaxin 11
237252_at THBD 6.7 1.5E5 Thrombomodulin
202085_at TJP2 1.8 2.0E4 Tight junction protein 2 (zona occludens 2)
231853_at TUBD1 1.6 2.4E3 Tubulin, d 1
Proteinaceous extracellular matrix
210809_s_at POSTN 1.8 4.9E3 Periostin, osteoblast specific factor
37022_at PRELP 1.6 3.2E3 Proline/arginine-rich end leucine-rich repeat protein
*Fold denotes fold change between presurgical and postsurgical conditions.
Huang et al Evolving Technology/Basic Science
The Journal of Thoracic and Cardiovascular Surgery c Volume 142, Number 5 1222.e13
E
T
/B
S
TABLE E9. Expression of transporter activity genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
Carbohydrate transport
200787_s_at PEA15 1.8 6.8E4 Phosphoprotein enriched in astrocytes 15
Electron transport chain
241755_at UQCRC2 1.7 3.2E3 Ibiquinol–cytochrome c reductase core protein II
Endoplasmic reticulum to Golgi vesiclemediated transport
212902_at SEC24A 1.8 1.2E3 SEC24-related gene family, member A (Saccharomyces cerevisiae)
Glucose transport
202932_at YES1 1.7 1.1E3 v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1
Glycolipid transport
227247_at PLEKHA8 1.5 2.2E3 Pleckstrin homology domain containing, family A (phosphoinositide-binding specific) member 8
Intracellular protein transmembrane transport
241425_at NUPL1 1.4 4.6E3 Nucleoporin-like 1
223225_s_at SEH1L 2.6 2.1E3 SEH1-like (S cerevisiae)
Intracellular protein transport
207624_s_at RPGR 1.7 9.7E4 Retinitis pigmentosa guanosine triphosphatase regulator
Metal ion transport
237648_x_at NHEDC2 1.6 1.9E3 Naþ/Hþ exchanger domain containing 2
243524_at SLC30A7 2.0 5.9E4 Solute carrier family 30 (zinc transporter), member 7
1561886_a_at SLC39A14 3.4 3.2E6 Solute carrier family 39 (zinc transporter), member 14
Neurotransmitter transport
1569916_at SLC6A15 2.1 6.6E4 Solute carrier family 6, member 15
Potassium ion transport
230192_at TRIM13 1.5 8.8E4 Tripartite motif-containing 13
Protein transport
229953_x_at LCA5 1.9 3.2E3 Leber congenital amaurosis 5
218708_at NXT1 2.6 1.8E4 NTF2-like export factor 1
221704_s_at VPS37B 1.5 3.5E3 Vacuolar protein sorting 37 homolog B (S cerevisiae)
211762_s_at KPNA2 2.4 1.3E3 Karyopherin a 2 (RAG cohort 1, importin a 1)
Retrograde axon cargo transport
208093_s_at NDEL1 1.9 1.1E4 nudE nuclear distribution gene E homolog (Aspergillus nidulans)like 1
Transporter activity
212168_at RBM12 1.6 2.5E3 RNA-binding motif protein 12
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E10. Expression of binding genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description
Antigen binding
202886_s_at PPP2R1B 1.7 1.7E3 Protein phosphatase 2 (formerly 2A), regulatory subunit A, b isoform
Adenosine triphosphate binding
230387_at ATP2C1 1.6 3.1E3 Adenosine triphosphatase, Ca2þ transporting, type 2C, member 1
224454_at ETNK1 4.0 5.3E5 Ethanolamine kinase 1
221918_at PCTK2 1.9 4.3E4 PCTAIRE protein kinase 2
227255_at PDIK1L 1.6 1.5E3 PDLIM1 interacting kinase 1 like
1568768_s_at RBKS 6.7 5.5E5 Ribokinase
236114_at RUNX1 2.7 3.3E4 Runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)
205214_at STK17B 3.3 2.0E3 Serine/threonine kinase 17b
Binding
1555281_x_at ARMC8 1.7 2.0E3 Armadillo repeat containing 8
221003_s_at CAB39L 2.0 3.1E4 Calcium binding protein 39–like
230289_at EPB41L1 2.4 3.9E3 Erythrocyte membrane protein band 4.1–like 1
226038_at LONRF1 1.6 3.7E4 LON peptidase N-terminal domain and ring finger 1
201761_at MTHFD2 2.4 2.0E4 methylenetetrahydrofolate dehydrogenase (nicotinamide adenine dinucleotide phosphateþ–dependent)
2, methylenetetrahydrofolate cyclohydrolase
202083_s_at SEC14L1 2.4 1.4E4 SEC14-like 1 (Saccharomyces cerevisiae)
229169_at TTC18 1.5 4.8E3 Tetratricopeptide repeat domain 18
1554588_a_at TTC30B 2.0 1.0E4 Tetratricopeptide repeat domain 30B
Calcium ion binding
225656_at EFHC1 1.9 2.4E4 EF-hand domain (C-terminal) containing 1
Carbohydrate binding
224826_at RP5–1022P6.2 1.7 1.7E3 Hypothetical protein KIAA1434
DNA binding
220936_s_at H2AFJ 1.7 2.5E3 H2A histone family, member J
205436_s_at H2AFX 1.8 3.5E3 H2A histone family, member X
211997_x_at H3F3B 1.9 9.8E5 H3 histone, family 3B (H3.3B)
232035_at HIST1H4H 2.2 1.8E3 Histone cluster 1, H4h
222139_at KIAA1466 1.7 4.1E3 KIAA1466 gene
1557852_at PHC2 2.2 6.4E4 Polyhomeotic homolog 2 (Drosophila)
217741_s_at ZFAND5 3.9 3.8E5 Zinc finger, AN1-type domain 5
Drug binding
203302_at DCK 1.7 2.0E3 Deoxycytidine kinase
Guanosine triphosphate binding
205140_at FPGT 1.7 1.0E3 Fucose-1-phosphate guanylyltransferase
209191_at TUBB6 3.0 1.9E4 Tubulin, b 6
Identical protein binding
200648_s_at GLUL 2.1 1.2E3 Glutamate-ammonia ligase (glutamine synthetase)
Iron-sulfur cluster binding
201873_s_at ABCE1 1.5 5.0E3 Adenosine triphosphate–binding cassette, subfamily E (OABP), member 1
Lipid binding
235985_at PITPNB 1.9 8.2E4 Phosphatidylinositol transfer protein, b
Magnesium ion binding
225613_at MAST4 1.9 4.0E3 Microtubule-associated serine/threonine kinase family member 4
206177_s_at ARG1 4.5 3.8E3 Arginase, liver
210005_at GART 1.7 1.3E3 Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase,
phosphoribosylaminoimidazole synthetase
Metal ion binding
1559391_s_at B4GALT5 2.2 1.9E4 UDP-Gal:bGlcNAc b 1,4- galactosyltransferase, polypeptide 5
200768_s_at MAT2A 2.5 1.2E4 methionine adenosyltransferase II, a
236699_at MBNL2 1.4 3.9E3 Muscleblind-like 2 (Drosophila)
241583_x_at SYT1 1.7 1.2E3 Synaptotagmin I
212665_at TIPARP 6.2 4.0E7 TCDD-inducible poly(adenosine diphosphate–ribose) polymerase
(Continued)
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TABLE E10. Continued
Probe set Symbol Fold* P value Description
218810_at ZC3H12A 2.1 5.9E4 Zinc finger CCCH-type containing 12A
201531_at ZFP36 4.5 2.2E6 Zinc finger protein 36, C3H type, homolog (mouse)
Nucleic acid binding
220359_s_at ARPP-21 6.0 2.4E4 Cyclic adenosine monophosphate–regulated phosphoprotein, 21 kDa
241858_at FPGT 2.0 2.7E3 Fucose-1-phosphate guanylyltransferase
224632_at GPATCH4 1.6 1.2E3 G patch domain containing 4
238829_at SPG11 1.5 3.2E3 Spastic paraplegia 11 (autosomal recessive)
230380_at THAP2 3.4 9.2E4 THAP domain containing, apoptosis-associated protein 2
228201_at ARL13B 1.7 9.2E4 adenosine diphosphate ribosylation factor–like 13B
219487_at BBS10 1.9 4.4E3 Bardet–Biedl syndrome 10
208896_at DDX18 1.6 2.3E3 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18
208152_s_at DDX21 3.1 4.6E4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21
1568815_a_at DDX50 1.7 8.0E4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 50
219243_at GIMAP4 1.7 3.0E3 Guonosine triphosphatase, IMAP family member 4
228071_at GIMAP7 2.0 6.5E4 Guanosine triphosphatase, IMAP family member 7
240452_at GSPT1 2.1 4.2E5 G1 to S phase transition 1
213076_at ITPKC 3.7 4.7E6 Inositol 1,4,5-trisphosphate 3-kinase C
223380_s_at LATS2 1.6 4.2E3 LATS, large tumor suppressor, homolog 2 (Drosophila)
238122_at RBM12B 1.8 2.1E4 RNA binding motif protein 12B
202693_s_at STK17A 2.0 2.7E3 Serine/threonine kinase 17a
Phosphoinositide binding
212923_s_at C6orf145 3.1 1.9E5 Chromosome 6 open reading frame 145
220330_s_at SAMSN1 6.7 1.0E3 SAM domain, SH3 domain, and nuclear localization signals 1
Protein binding
218723_s_at C13orf15 2.6 2.3E4 Chromosome 13 open reading frame 15
230424_at C5orf13 1.7 1.7E3 Chromosome 5 open reading frame 13
236634_at C8orf48 1.6 3.5E3 Chromosome 8 open reading frame 48
205899_at CCNA1 1.5 3.2E3 Cyclin A1
218351_at COMMD8 1.6 3.3E3 COMM domain containing 8
208892_s_at DUSP6 2.5 2.4E3 Dual specificity phosphatase 6
220386_s_at EML4 1.7 6.2E4 Echinoderm microtubule-associated protein–like 4
224657_at ERRFI1 4.0 1.2E6 ERBB receptor feedback inhibitor 1
214509_at HIST1H3I 1.6 2.8E3 Histone cluster 1, H3i
225142_at JHDM1D 1.6 3.3E3 Jumonji C domain-containing histone demethylase 1 homolog D (S cerevisiae)
226479_at KBTBD6 1.8 2.5E3 Kelch repeat and BTB (POZ) domain containing 6
223412_at KBTBD7 2.0 2.4E4 Kelch repeat and BTB (POZ) domain containing 7
243589_at KIAA1267 1.6 3.2E3 KIAA1267
226370_at KLHL15 1.7 3.7E3 Kelch-like 15 (Drosophila)
203068_at KLHL21 1.6 2.8E3 Kelch-like 21 (Drosophila)
1559580_at LRRC39 3.1 6.0E4 Leucine-rich repeat containing 39
200712_s_at MAPRE1 1.4 3.5E3 Microtubule-associated protein, RP/EB family, member 1
225478_at MFHAS1 1.9 2.3E4 Malignant fibrous histiocytoma amplified sequence 1
223397_s_at NIP7 2.7 8.3E4 Nuclear import 7 homolog (S cerevisiae)
1555310_a_at PAK6 1.7 8.1E4 p21 (CDKN1A)–activated kinase 6
211564_s_at PDLIM4 1.8 2.2E3 PDZ and LIM domain 4
202464_s_at PFKFB3 3.8 1.4E4 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
200919_at PHC2 2.0 2.5E3 Polyhomeotic homolog 2 (Drosophila)
217996_at PHLDA1 3.8 7.9E4 Pleckstrin homology–like domain, family A, member 1
209317_at POLR1C 1.9 1.3E3 Polymerase (RNA) I polypeptide C, 30 kDa
37028_at PPP1R15A 2.2 1.7E3 Protein phosphatase 1, regulatory (inhibitor) subunit 15A
205178_s_at RBBP6 1.8 2.0E4 Retinoblastoma binding protein 6
225039_at RPE 1.5 2.5E3 Ribulose-5-phosphate-3-epimerase
209486_at SAS10 2.0 1.2E3 Disrupter of silencing 10
236606_at SAV1 1.5 1.2E3 Salvador homolog 1 (Drosophila)
226337_at SCYL1BP1 1.9 2.1E3 SCY1-like 1 binding protein 1
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Probe set Symbol Fold* P value Description
219480_at SNAI1 1.6 3.0E3 Snail homolog 1 (Drosophila)
218335_x_at TNIP2 1.6 4.3E3 TNFAIP3 interacting protein 2
235081_x_at TRIM65 1.7 8.6E4 Tripartite motif-containing 65
233970_s_at TRMT6 1.6 1.1E3 Transfer RNA methyltransferase 6 homolog (S cerevisiae)
218156_s_at TSR1 1.6 1.5E3 TSR1, 20S ribonuclear RNA accumulation, homolog (S cerevisiae)
209251_x_at TUBA1C 1.5 2.4E3 Tubulin, a 1c
218647_s_at YRDC 2.0 2.3E4 yrdC domain containing (E coli)
218214_at C12orf44 1.5 1.5E3 Chromosome 12 open reading frame 44
211947_s_at BAT2D1 1.5 2.7E3 BAT2 domain containing 1
213918_s_at NIPBL 1.7 2.0E4 Nipped-B homolog (Drosophila)
218738_s_at RNF138 1.8 2.7E3 Ring finger protein 138
Rab guanosine triphosphatase binding
222333_at ALS2CL 1.9 4.6E4 ALS2 C-terminal like
RNA binding
224956_at NUFIP2 1.8 4.8E3 Nuclear fragile X mental retardation protein interacting protein 2
236907_at PABPC1 2.2 9.7E4 Poly(A) binding protein, cytoplasmic 1
220104_at ZC3HAV1 2.1 4.0E4 Zinc finger CCCH-type, antiviral 1
201369_s_at ZFP36L2 2.2 2.2E5 Zinc finger protein 36, C3H type–like 2
201530_x_at EIF4A1 2.6 4.5E4 Eukaryotic translation initiation factor 4A, isoform 1
Single-stranded DNA binding
233085_s_at OBFC2A 2.7 5.4E4 Oligonucleotide/oligosaccharide-binding fold containing 2A
Spermidine binding
213988_s_at SAT1 2.8 2.8E4 Spermidine/spermine N1-acetyltransferase 1
Unfolded protein binding
208977_x_at TUBB2C 1.6 3.3E3 Tubulin, b 2C
Zinc ion binding
231270_at CA13 1.7 3.7E3 Carbonic anhydrase XIII
223800_s_at LIMS3 2.4 5.1E5 LIM and senescent cell antigen–like domains 3
202643_s_at TNFAIP3 3.2 2.1E3 Tumor necrosis factor a–induced protein 3
211965_at ZFP36L1 3.0 4.5E5 Zinc finger protein 36, C3H type–like 1
*Fold denotes fold change between presurgical and postsurgical conditions.
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TABLE E11. Expression of miscellaneous and unknown genes in the diaphragm during cardiothoracic surgery
Probe set Symbol Fold* P value Description Function
226621_at FGG 3.0 3.9E5 Fibrinogen g chain Associates with IL31RA to form the interleukin 31
receptor
242836_at ATP1B3 2.6 4.2E4 Adenosine triphosphatase, Naþ/Kþ transporting, b 3
polypeptide
Adenosine triphosphate metabolism
241916_at PLSCR1 1.8 6.3E4 Phospholipid scramblase 1 Blood coagulation
242868_at EPAS1 2.2 3.0E5 Endothelial PAS domain protein 1 Blood vessel development
240815_at SEMA3C 1.7 2.9E3 Sema domain, immunoglobulin domain (Ig), short
basic
domain, secreted, (semaphorin) 3C
Blood vessel development
231999_at ANKRD11 1.5 4.3E3 Ankyrin repeat domain 11 Bone development
209585_s_at MINPP1 1.6 3.8E3 Multiple inositol polyphosphate histidine
phosphatase, 1
Bone development
1562275_at ADAMTS9 8.4 7.4E5 ADAM metallopeptidase with thrombospondin type
1 motif, 9
Cleaves the large aggregating proteoglycans,
aggrecan and versican
225699_at SNORA9 2.5 5.7E5 Small nucleolar RNA, H/ACA box 9 Core component of the SMC5-SMC6 complex,
a complex involved in DNA double-strand breaks
by homologous recombination
1562948_at SMC5 1.5 4.1E3 Structural maintenance of chromosomes 5 DNA metabolic process
242116_x_at ANKRD17 1.6 2.6E3 Ankyrin repeat domain 17 Earliest specific in situ marker of hepatic
differentiation during embryogenesis
218361_at GOLPH3L 1.9 2.2E3 Golgi phosphoprotein 3–like Golgi apparatus
225912_at TP53INP1 1.9 4.8E3 Tumor protein p53 inducible nuclear protein 1 In response to double-strand DNA breaks, promotes
p53/TP53 phosphorylation on Ser-46 and
subsequent apoptosis
228772_at HNMT 1.8 4.4E3 Histamine N-methyltransferase Inactivates histamine by N-methylation; plays an
important role in degrading histamine and in
regulating airway response to histamine
1565638_at PMP22 1.6 4.9E3 Peripheral myelin protein 22 Involved in growth regulation and in myelinization in
the peripheral nervous system
234639_x_at KRTAP9-8 1.7 3.6E3 Keratin-associated protein 9–8 Keratin filament
201196_s_at AMD1 2.3 1.1E3 Adenosylmethionine decarboxylase 1 Lyase activity
214911_s_at BRD2 1.7 4.1E3 Bromodomain containing 2 May play a role in spermatogenesis or
folliculogenesis
237007_at KCNB2 1.6 8.3E4 Potassium voltage-gated channel, Shab-related
subfamily, member 2
Mediates the voltage-dependent potassium ion
permeability of excitable membranes
230333_at SAT1 1.8 4.1E3 Spermidine/spermine N1-acetyltransferase 1 N-acyltransferase activity
222142_at CYLD 1.4 3.3E3 Cylindromatosis (turban tumor syndrome) Negative regulator of TRAF2 and neutral factor kB
signaling pathway
202238_s_at NNMT 4.0 1.0E5 Nicotinamide N-methyltransferase N-methyltransferase activity
203023_at HSPC111 1.9 5.4E4 Hypothetical protein HSPC111 Nuclear lumen
211686_s_at RBM13 1.7 3.6E3 RNA-binding motif protein 13 Nuclear lumen
203234_at UPP1 3.2 1.0E4 Uridine phosphorylase 1 Nucleobase, nucleoside, nucleotide, and nucleic acid
metabolic process
238902_at PCMTD1 1.5 2.0E3 Protein-L-isoaspartate (D-aspartate)
O-methyltransferase
domain containing 1
O-methyltransferase activity
209457_at DUSP5 2.5 2.8E5 Dual specificity phosphatase 5 Phosphatase activity
239516_at LYPLAL1 3.5 2.3E4 Lysophospholipase-like 1 Phosphatase activity
209803_s_at PHLDA2 3.5 1.2E5 Pleckstrin homology–like domain, family A,
member 2
Plays a role in regulating placenta growth
219677_at SPSB1 2.3 7.8E5 splA/ryanodine receptor domain and SOCS box
containing 1
Substrate recognition component of SCF-like ECS
complex
223580_at SPSB2 1.5 2.6E3 splA/ryanodine receptor domain and SOCS box
containing 2
Substrate recognition component of SCF-like ECS
complex
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204014_at DUSP4 1.8 4.7E3 Dual specificity phosphatase 4 Regulates mitogenic signal transduction by
dephosphorylating both Thr and Tyr residues on
MAP kinases ERK1 and ERK2
227621_at WTAP 2.5 3.3E3 Wilms tumor 1 associated protein RNA splicing
215095_at ESD 1.5 3.7E3 Esterase D/formylglutathione hydrolase Serine hydrolase involved in the detoxification of
formaldehyde
235419_at ERRFI1 2.1 6.9E5 ERBB receptor feedback inhibitor 1 Small guanosine triphosphatase regulator activity
203276_at LMNB1 4.0 5.0E4 Lamin B1 Structural molecular activity
225735_at ANKRD50 1.5 3.4E3 Ankyrin repeat domain 50 Unknown
226055_at ARRDC2 1.7 7.6E4 Arrestin domain containing 2 Unknown
229437_at BIC 2.7 8.4E4 BIC transcript Unknown
226383_at C11orf46 1.7 3.2E3 Chromosome 11 open reading frame 46 Unknown
227058_at C13orf33 4.0 1.4E4 Chromosome 13 open reading frame 33 Unknown
227446_s_at C14orf167 1.9 3.3E3 Chromosome 14 open reading frame 167 Unknown
212643_at C14orf32 1.4 3.6E3 Chromosome 14 open reading frame 32 Unknown
223474_at C14orf4 1.6 3.9E3 Chromosome 14 open reading frame 4 Unknown
217682_at C16orf72 1.9 3.7E4 Chromosome 16 open reading frame 72 Unknown
213528_at C1orf156 1.8 6.2E4 Chromosome 1 open reading frame 156 Unknown
244103_at C1orf55 1.7 1.9E3 Chromosome 1 open reading frame 55 Unknown
209020_at C20orf111 1.7 3.0E3 Chromosome 20 open reading frame 111 Unknown
241484_x_at C20orf80 1.5 2.9E3 Chromosome 20 open reading frame 80 Unknown
1552605_s_at C21orf74 1.5 2.3E3 Chromosome 21 open reading frame 74 Unknown
228067_at C2orf55 2.4 8.4E4 Chromosome 2 open reading frame 55 Unknown
222309_at C6orf62 2.4 3.0E3 Chromosome 6 open reading frame 62 Unknown
222706_at CCDC49 1.5 3.7E3 Coiled-coil domain containing 49 Unknown
1553214_a_at CCDC7 1.7 2.7E3 Coiled-coil domain containing 7 Unknown
227517_s_at CENPL 2.0 6.7E4 Centromere protein L Unknown
229718_at CG018 1.9 1.9E3 Hypothetical gene CG018 Unknown
224991_at CMIP 1.9 4.7E3 c-Maf–inducing protein Unknown
1563536_at COL4A5 1.5 1.4E3 Collagen, type IV, a 5 (Alport syndrome) Unknown
219397_at COQ10B 1.9 3.4E4 Coenzyme Q10 homolog B (Saccharomyces
cerevisiae)
Unknown
1563445_x_at CTSLL3 2.5 1.5E5 Cathepsin L–like 3 Unknown
227520_at CXorf15 1.6 4.6E3 Chromosome X open reading frame 15 Unknown
1556114_a_at DKFZp451A211 3.2 2.3E4 DKFZp451A211 protein Unknown
1569987_at DLEU7 1.5 4.5E3 Deleted in lymphocytic leukemia, 7 Unknown
236649_at DTWD1 1.8 9.5E4 DTW domain containing 1 Unknown
1563315_s_at ERICH1 1.8 9.3E4 Glutamate-rich 1 Unknown
219216_at ETAA1 2.0 1.2E3 Ewing tumor–associated antigen 1 Unknown
223038_s_at FAM60A 1.7 3.7E3 Family with sequence similarity 60, member A Unknown
244014_x_at FAM92A1 1.6 3.8E3 Family with sequence similarity 92, member A1 Unknown
1553797_a_at FLJ30594 2.3 4.4E3 Hypothetical locus FLJ30594 Unknown
229521_at FLJ36031 4.8 8.0E7 Hypothetical protein FLJ36031 Unknown
239331_at FLJ43663 2.7 1.1E4 Hypothetical protein FLJ43663 Unknown
236583_at GIMAP5 1.7 2.3E3 Guanosine triphosphatase, IMAP family member 5 Unknown
233599_at hCG_2003663 1.7 8.3E4 hCG2003663 Unknown
202081_at IER2 2.9 1.8E3 Immediate early response 2 Unknown
218611_at IER5 2.6 1.3E3 Immediate early response 5 Unknown
203143_s_at KIAA0040 4.2 6.6E6 KIAA0040 Unknown
228325_at KIAA0146 5.6 2.0E7 KIAA0146 Unknown
225924_at KIAA1450 1.8 1.5E3 KIAA1450 protein Unknown
228334_x_at KIAA1712 1.6 2.7E3 KIAA1712 Unknown
231828_at LOC253039 2.1 3.0E3 Hypothetical protein LOC253039 Unknown
235151_at LOC283357 1.6 3.5E3 Hypothetical protein LOC283357 Unknown
229007_at LOC283788 1.7 4.1E3 Hypothetical protein LOC283788 Unknown
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234141_s_at LOC286059 1.8 2.5E3 Hypothetical protein LOC286059 Unknown
227099_s_at LOC387763 3.8 1.7E4 Hypothetical LOC387763 Unknown
225857_s_at LOC388796 1.8 8.1E4 Hypothetical LOC388796 Unknown
228603_at LOC440900 1.5 2.2E3 Hypothetical LOC440900 Unknown
230595_at LOC572558 1.5 2.9E3 Hypothetical locus LOC572558 Unknown
220770_s_at LOC63920 2.3 2.2E4 Transposon-derived Buster3 transposase-like Unknown
203742_s_at LOC645233 1.5 4.5E3 Similar to G/T mismatch–specific thymine DNA
glycosylase
Unknown
240421_x_at LOC646561 1.8 2.7E3 Similar to WW45 protein Unknown
239343_at LOC728705 1.4 3.3E3 Hypothetical protein LOC728705 Unknown
1556180_at LOC729678 1.6 4.1E3 Hypothetical protein LOC729678 Unknown
215322_at LONRF1 1.8 2.9E3 LON peptidase N-terminal domain and ring finger 1 Unknown
224558_s_at MALAT1 1.4 4.2E3 Metastasis-associated lung adenocarcinoma
transcript 1 (noncoding RNA)
Unknown
213761_at MDM1 1.6 3.1E3 Mdm4, transformed 3T3 cell double minute 1, p53
binding protein (mouse)
Unknown
214696_at MGC14376 2.5 4.0E4 Hypothetical protein MGC14376 Unknown
236273_at NBPF1 1.4 4.7E3 Neuroblastoma breakpoint family, member 1 Unknown
1565875_at NUP153 1.6 2.3E3 Nucleoporin 153kDa Unknown
218319_at PELI1 3.0 5.5E4 Pellino homolog 1 (Drosophila) Unknown
219093_at PID1 1.8 5.0E3 Phosphotyrosine interaction domain containing 1 Unknown
1570046_at SCRG1 1.5 2.7E3 Scrapie responsive protein 1 Unknown
214965_at SPATA2L 1.9 3.3E3 Spermatogenesis associated 2–like Unknown
224917_at TMEM49 4.3 4.1E5 Transmembrane protein 49 Unknown
1561705_at TTBK2 1.6 1.9E3 Tau tubulin kinase 2 Unknown
233242_at WDR73 1.5 4.8E3 WD repeat domain 73 Unknown
228280_at ZC3HAV1L 1.6 4.9E3 Zinc finger CCCH-type, antiviral 1–like Unknown
1554007_at ZNF483 2.4 3.4E3 Zinc finger protein 483 Unknown
*Fold denotes fold change between presurgical and postsurgical conditions.
TABLE E12. Quantitative real-time reverse transcriptase polymerase chain reaction target information
Gene symbol NCBI gene reference Assay ID Amplicon length Context sequence
MEF2C NM_001131005.1 Hs00231149_m1 101 CAGGCACCAGTGCAGGGAACGGGTA
FBXO32 NM_148177.1 Hs01041408_m1 70 CGGCAGATCCGCAAACGATTAATTC
TRIM63 NM_032588.2 Hs00822397_m1 63–94 TCCCGTCGAGTGACCAAGGAGAACA
CTSL1 NM_145918.2 Hs00377632_m1 85 GAAGAACAGCTGGGGTGAAGAATGG
SOD2 NM_001024465.1 Hs00167309_m1 67 AGGAACAACAGGCCTTATTCCACTG
POLR2A NM_000937.3 Hs01108291_m1 86 GCTATAAGGTGGAACGGCACATGTG
B2M NM_004048.2 Hs99999907_m1 75 AGTGGGATCGAGACATGTAAGCAGC
NCBI, National Center for Biotechnology Information.
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